https://curecurrent.com/trials/the-periodontal-disease-and-diabetes-mellitus-interrelationship-among-adult-malaysians-22433 https://curecurrent.com/trials/efficacy-and-safety-of-oral-acarbose-treatment-in-patients-with-type-2-diabetes-mellitus-22434 https://curecurrent.com/trials/closing-the-loop-in-youth-with-type-1-diabetes-in-the-home-setting-22435 https://curecurrent.com/trials/rule-based-closed-loop-system-for-type-1-diabetes-control-22436 https://curecurrent.com/trials/effectiveness-study-of-hydrotherapy-against-pain-and-other-symptoms-in-diabetes-induced-lead-22437 https://curecurrent.com/trials/the-role-of-nitazoxanide-interferon-alfa-and-ribavirin-in-treatment-of-hepatitis-c-infected-type-2-diabetic-patients-22438 https://curecurrent.com/trials/hyperbaric-oxygen-treatment-ameliorates-insulin-resistance-22439 https://curecurrent.com/trials/prospective-cohort-study-of-the-body-constitution-among-type-ii-diabetes-mellitus-patients-22440 https://curecurrent.com/trials/vitamin-c-supplementation-plus-hypoglycemic-agents-versus-hypoglycemic-agents-alone-in-type-2-diabetes-mellitus-22441 https://curecurrent.com/trials/ready-to-act-health-education-in-people-with-hyperglycaemia-22442 https://curecurrent.com/trials/early-feasibility-study-2-of-outpatient-control-to-range-testing-system-efficacy-france-22443 https://curecurrent.com/trials/study-to-evaluate-safety-and-tolerability-of-pegaptanib-sodium-in-patients-with-diabetic-macular-edema-22444 https://curecurrent.com/trials/effect-of-atorvastatin-on-vascular-inflammation-in-type-2-diabetes-22445 https://curecurrent.com/trials/japan-prevention-trial-of-diabetes-by-pitavastatin-in-patients-with-impaired-glucose-tolerance-j-predict-22446 https://curecurrent.com/trials/the-effects-of-glp-1-in-maturity-onset-diabetes-of-the-young-mody-22447 https://curecurrent.com/trials/influence-of-glitazones-on-the-vasodilatory-effect-of-high-density-lipoprotein-hdl-lipoproteins-22448 https://curecurrent.com/trials/bone-marrow-progenitor-cell-mobilization-in-diabetes-22449 https://curecurrent.com/trials/the-smart-oracle-study-22450 https://curecurrent.com/trials/study-to-assess-the-effect-of-24-weeks-of-treatment-with-vildagliptin-in-patients-with-type-2-diabetes-22451 https://curecurrent.com/trials/comparison-of-pk-after-administration-of-hcp1201-and-co-administration-of-metformin-sr-750mg-and-rosuvastatin-20mg-22452 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-50mg-bid-as-an-add-on-therapy-to-insulin-with-or-without-metformin-in-patients-with-22453 https://curecurrent.com/trials/hypoglycemic-effects-of-fermented-red-ginseng-in-subject-with-impaired-fasting-glucose-or-type-2-diabetes-22454 https://curecurrent.com/trials/a-3-fold-crossover-bioequivalence-study-between-glucobay-orally-disintegrating-tablet-odt-and-glucobay-standard-tablet-22455 https://curecurrent.com/trials/evaluating-a-pharmacokinetic-drug-interaction-between-metformin-hydrochloride-and-rosuvastatin-calcium-22456 https://curecurrent.com/trials/body-weight-effects-on-glucophage-s-efficacy-in-chinese-diagnosed-t2dm-patients-22457 https://curecurrent.com/trials/polymorphids-an-mrna-expression-in-obese-genes-22458 https://curecurrent.com/trials/endothelial-function-in-hispanic-children-adolescents-at-risk-for-type-2-diabetes-22459 https://curecurrent.com/trials/effect-of-different-interventions-on-glycemic-control-and-cell-function-in-newly-diagnosed-type-2-diabetic-patients-22460 https://curecurrent.com/trials/repeated-dose-study-with-a-new-insulin-glargine-formulation-and-lantus-on-24-hour-glucose-profile-in-japanese-patients-w-22461 https://curecurrent.com/trials/study-to-evaluate-safety-and-pk-pd-of-da-3091-in-healthy-male-subjects-22462 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-da-3030-and-to-explore-the-efficacy-for-diabetic-neuropathic-pain-22463 https://curecurrent.com/trials/effects-of-5-day-statin-withdrawal-on-endothelial-progenitor-cells-and-inflammatory-markers-in-type-2-diabetic-patients-22464 https://curecurrent.com/trials/euglycemic-clamp-study-comparing-two-new-insulin-glargine-formulations-in-subjects-with-type-1-diabetes-mellitus-22465 https://curecurrent.com/trials/single-dose-2-way-crossover-open-study-to-evaluate-the-food-effect-on-the-pk-of-hcp1201-in-healthy-volunteers-22466 https://curecurrent.com/trials/a-study-to-compare-safety-and-efficacy-of-tramadol-hydrochloride-acetaminophen-with-gabapentin-in-participants-with-diab-22467 https://curecurrent.com/trials/diabetic-foot-and-vascular-progenitor-cells-22468 https://curecurrent.com/trials/very-low-density-lipoprotein-triglyceride-vldl-tg-metabolism-during-acute-hyperglycemia-22469 https://curecurrent.com/trials/metformin-as-adjuvant-to-insulin-therapy-in-insulin-resistant-diabetes-mellitus-with-pregnancy-22470 https://curecurrent.com/trials/a-clinical-trial-to-study-the-efficacy-safety-tolerability-and-pharmacokinetics-of-p2202-in-patients-of-type-2-diabetes-22471 https://curecurrent.com/trials/liraglutide-and-insulin-therapy-in-patients-with-type-2-diabetes-22472 https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-and-distribution-and-activity-in-the-body-of-nnc0148-0000-0287-injected-un-22473 https://curecurrent.com/trials/the-effect-of-korean-red-ginseng-supplementation-on-glucose-control-22474 https://curecurrent.com/trials/additional-glp-1-analogue-on-csii-treatment-for-poorly-controlled-type-2-diabetic-patients-22475 https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-insulin-sensitivity-in-chinese-gestational-diabetic-patients-22476 https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-properties-of-biod-123-and-biod-125-compared-to-humalog-in-subjects-with-type-1-diab-22477 https://curecurrent.com/trials/management-of-albuminuria-in-hypertensive-diabetics-22478 https://curecurrent.com/trials/clinical-trial-on-diabetes-expert-patients-programme-22479 https://curecurrent.com/trials/cord-blood-infusion-for-type-1-diabetes-mellitus-t1dm-22480 https://curecurrent.com/trials/effects-of-legume-intake-on-cardiovascular-risk-factors-among-adults-at-risk-for-diabetes-22481 https://curecurrent.com/trials/a-safety-and-efficacy-study-for-tapentadol-cg5503-extended-release-for-patients-with-painful-diabetic-peripheral-neuropa-22482 https://curecurrent.com/trials/a-comparison-chocolate-with-and-without-high-cocoa-solids-in-patients-with-type-2-diabetes-in-a-randomised-clinical-tria-22483 https://curecurrent.com/trials/an-evaluation-of-glycemic-control-effects-of-mono-therapy-ckd-501-in-patients-with-type-2-diabetes-mellitus-22484 https://curecurrent.com/trials/a-study-to-evaluate-safety-and-pharmacokinetics-pharmacodynamics-of-sustained-release-sr-exenatide-22485 https://curecurrent.com/trials/clinical-verification-of-peptide-biomarkers-for-type-2-diabetes-mellitus-22486 https://curecurrent.com/trials/periodontal-treatment-and-glycemic-control-22487 https://curecurrent.com/trials/a-randomized-trial-to-assess-the-efficacy-and-safety-of-go2ka1-chitosan-oligosaccharide-on-blood-glucose-control-22488 https://curecurrent.com/trials/mdrs-for-prevention-of-nocturnal-hypoglycemia-22489 https://curecurrent.com/trials/effect-of-acute-exercise-on-endothelial-function-in-patients-with-type-1-diabetes-22490 https://curecurrent.com/trials/reduction-of-foveal-sensitivity-in-eyes-with-diabetic-macular-edema-22491 https://curecurrent.com/trials/teamcare-pcn-collaborative-care-for-diabetes-and-depression-22492 https://curecurrent.com/trials/healthy-eating-active-living-for-diabetes-in-primary-care-networks-22493 https://curecurrent.com/trials/long-term-treatment-effect-of-diapep277-in-type-1-diabetes-22494 https://curecurrent.com/trials/dietary-effects-on-circulating-lipoprotein-associated-phospholipase-a2-lp-pla2-activity-and-enzyme-activity-in-periphera-22495 https://curecurrent.com/trials/triple-therapy-in-type-2-diabetic-patients-22496 https://curecurrent.com/trials/the-effects-of-regular-home-use-vs-diabetic-team-supported-use-of-the-medtronic-carelink-therapy-management-system-22497 https://curecurrent.com/trials/mk-0431-ono-5435-phase-iii-clinical-trial-rapid-acting-insulin-secretagogue-add-on-study-in-patients-with-type-2-diabete-22498 https://curecurrent.com/trials/diabetes-peripheral-neuropathy-and-small-fibre-nerve-damage-a-comparative-study-22499 https://curecurrent.com/trials/the-effect-of-intensive-multifactorial-therapy-on-endothelial-function-in-newly-diagnosed-type-2-diabetes-22500 https://curecurrent.com/trials/evaluation-of-the-effectiveness-and-safety-of-physician-versus-patient-led-of-insulin-glargine-initiation-and-titration-22501 https://curecurrent.com/trials/comparison-of-insulin-glargine-insulin-glulisine-regimen-to-insulin-aspart-insulin-aspart-protamine-30-70-in-type-2-diab-22502 https://curecurrent.com/trials/use-of-the-freestyle-navigator-continuous-glucose-monitoring-system-to-enhance-education-and-glycaemic-control-22503 https://curecurrent.com/trials/a-long-term-trial-to-compare-the-effects-of-liraglutide-and-sulphonylurea-glimepiride-both-in-combination-with-metformin-22504 https://curecurrent.com/trials/treatment-by-insulin-continuous-infusion-in-type-2-diabetes-22505 https://curecurrent.com/trials/biphasic-insulin-aspart-versus-nph-plus-regular-human-insulin-in-type-2-diabetic-patients-22506 https://curecurrent.com/trials/metformin-therapy-in-type-1-diabetes-mellitus-22507 https://curecurrent.com/trials/care-china-diabetes-22508 https://curecurrent.com/trials/the-effects-of-short-term-exenatide-therapy-in-newly-diagnosed-type-2-diabetic-patients-22509 https://curecurrent.com/trials/influence-of-catheter-based-renal-denervation-in-diseases-with-increased-sympathetic-activity-22510 https://curecurrent.com/trials/diabetes-treatment-with-glucobay-in-combination-with-sulfonylurea-22511 https://curecurrent.com/trials/glucose-variability-in-pregnancy-complicated-by-diabetes-22512 https://curecurrent.com/trials/effect-of-dietary-fiber-on-glucose-lipids-in-non-insulin-dependent-diabetes-mellitus-niddm-22513 https://curecurrent.com/trials/glucofriend-evaluation-the-effectiveness-of-glucobay-when-combined-with-a-basal-insulin-22514 https://curecurrent.com/trials/impact-of-sleep-education-program-on-glycemic-control-in-hong-kong-chinese-type-2-diabetic-patients-22515 https://curecurrent.com/trials/apad2-effects-of-rehabilitation-programme-in-adapted-physical-activity-apa-among-type-2-diabetics-22516 https://curecurrent.com/trials/effects-of-dietary-polyphenols-and-3-fatty-acids-on-cardiovascular-risk-factors-in-high-risk-subjects-22517 https://curecurrent.com/trials/ex-vivo-lps-stimulation-in-healthy-and-compromised-subjects-22518 https://curecurrent.com/trials/autologous-transplantation-of-mesenchymal-stem-cells-for-treatment-of-patients-with-onset-of-type-1-diabetes-22519 https://curecurrent.com/trials/effect-of-modifying-anti-platelet-treatment-to-ticagrelor-in-patients-with-diabetes-and-low-response-to-clopidogrel-22520 https://curecurrent.com/trials/living-successfully-with-chronic-eye-diseases-22521 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ev-077-in-type-2-diabetic-subjects-22522 https://curecurrent.com/trials/a-3-fold-crossover-bioequivalence-study-between-glucobay-odt-orally-disintegrating-tablet-100-mg-and-glucobay-standard-t-22523 https://curecurrent.com/trials/immunogenicity-safety-and-tolerability-of-an-mf59-adjuvanted-versus-non-adjuvanted-influenza-vaccines-in-patients-with-c-22524 https://curecurrent.com/trials/vitamin-d-and-omega-3-inhibit-metabolic-syndrome-22525 https://curecurrent.com/trials/the-effect-of-vitamin-d-on-the-serum-thioredoxin-tbp-2-thioredoxin-reductase-gene-expression-of-tbp-2-in-patients-with-t-22526 https://curecurrent.com/trials/serum-and-intraocular-levels-of-erythropoietin-and-vegf-in-type-2-diabetes-patients-with-proliferative-retinopathy-22527 https://curecurrent.com/trials/proteomics-study-of-gastric-bypass-surgery-to-treat-type-2-diabetes-mellitus-22528 https://curecurrent.com/trials/serum-1-25-dihydroxyvitamin-d-levels-in-type-2-diabetes-mellitus-patients-with-different-levels-of-albuminuria-22529 https://curecurrent.com/trials/effect-of-the-biomarker-copeptin-in-managing-patients-with-suspected-acute-coronary-syndrome-acs-22530 https://curecurrent.com/trials/ulcer-monitoring-in-diabetes-mellitus-22531 https://curecurrent.com/trials/prospective-observational-study-assessing-treatment-and-outcomes-of-patients-with-prediabetes-22532 https://curecurrent.com/trials/optimizing-audit-and-feedback-for-primary-care-22533 https://curecurrent.com/trials/effects-of-benfotiamine-on-intraepidermal-nerve-fiber-density-ienfd-22534 https://curecurrent.com/trials/effects-of-high-voltage-electrical-stimulation-shortwave-diathermy-and-kinesiotherapy-on-arterial-blood-flow-in-the-lowe-22535 https://curecurrent.com/trials/a-trial-to-study-the-effect-of-vitamin-d-supplementation-on-glucose-and-insulin-metabolism-in-centrally-obese-men-22536 https://curecurrent.com/trials/efficacy-safety-tolerability-and-pharmacokinetics-of-concomitant-administration-of-tramadol-with-duloxetine-or-pregabali-22537 https://curecurrent.com/trials/better-acceptance-of-single-injection-apidra-added-to-once-daily-lantus-versus-twice-daily-premixed-insulin-in-real-life-22538 https://curecurrent.com/trials/efficacy-and-safety-of-kw21052-compared-to-lyrica-in-the-diabetic-patients-with-neuropathic-pain-22539 https://curecurrent.com/trials/study-on-periodontal-treatment-in-diabetic-patients-22540 https://curecurrent.com/trials/efficacy-and-safety-of-add-on-therapy-with-dlbs3233-in-patients-with-type-2-diabetes-mellitus-22541 https://curecurrent.com/trials/efficacy-of-alogliptin-and-with-pioglitazone-in-patients-with-type-2-diabetes-22542 https://curecurrent.com/trials/analisys-of-neuromuscular-response-postural-balance-and-quality-of-life-of-diabetics-type-2-after-sensory-motor-training-22543 https://curecurrent.com/trials/effect-of-ginseng-on-glycemic-control-22544 https://curecurrent.com/trials/effects-of-berries-and-berry-fractions-on-metabolic-diseases-22545 https://curecurrent.com/trials/a-study-of-improved-efficacy-safety-and-compliance-to-administer-insulin-in-pen-vs-vial-and-syringe-22546 https://curecurrent.com/trials/the-effect-of-metformin-in-overweight-patients-with-dysregulated-type-1-diabetes-mellitus-22547 https://curecurrent.com/trials/metformin-treatment-in-gestational-diabetes-and-noninsulin-dependent-diabetes-in-pregnancy-in-a-developing-country-22548 https://curecurrent.com/trials/safety-and-efficacy-of-sitagliptin-added-to-insulin-therapy-for-type-2-diabetes-22549 https://curecurrent.com/trials/study-of-single-ascending-doses-of-pbl-1427-in-healthy-volunteers-22550 https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-in-type-2-diabetes-22551 https://curecurrent.com/trials/a-pharmacokinetic-study-to-compare-co-administration-of-repaglinide-and-metformin-hcl-to-administration-of-combination-p-22552 https://curecurrent.com/trials/thyroid-study-type-2-diabetes-mellitus-t2dm-22553 https://curecurrent.com/trials/cross-over-study-on-effect-of-lipid-lowering-by-acipimox-on-cardiac-and-skeletal-muscle-mitochondrial-function-22554 https://curecurrent.com/trials/safety-and-efficacy-of-spirinolactone-plus-hydroflumethiazide-in-the-treatment-of-filipino-patients-with-hypertension-22555 https://curecurrent.com/trials/multicentre-randomized-controlled-trial-of-qideng-mingmu-capsule-in-the-treatment-of-diabetic-retinopathy-22556 https://curecurrent.com/trials/effects-of-vitamin-b1-in-type-1-diabetic-patients-22557 https://curecurrent.com/trials/a-pilot-study-to-assess-the-safety-pk-and-pd-of-insulin-injected-via-micronjet-or-conventional-needle-22558 https://curecurrent.com/trials/hyperbaric-oxygen-therapy-hbot-for-chronic-diabetic-lower-limb-ulcers-22559 https://curecurrent.com/trials/a-study-of-the-effect-of-a-chronic-disease-management-system-on-diabetes-care-within-multidisciplinary-primary-care-prac-22560 https://curecurrent.com/trials/effectiveness-of-two-interventions-in-patients-with-low-educational-level-with-diabetes-to-reduce-inequalities-in-self-c-22561 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-cilostazol-and-probucol-in-combination-on-patients-with-diabetic-22562 https://curecurrent.com/trials/cardiovascular-effects-of-chronic-sildenafil-in-men-with-type-2-diabetes-22563 https://curecurrent.com/trials/continuous-subcutaneous-insulin-infusion-strategy-versus-multiple-daily-insulin-injections-strategy-22564 https://curecurrent.com/trials/fetal-heart-interventricular-septum-in-fetuses-of-diabetic-mothers-22565 https://curecurrent.com/trials/trientine-hydrochloride-for-the-prevention-of-macular-edema-associated-with-pan-retinal-photocoagulation-for-severe-non-22566 https://curecurrent.com/trials/comparison-of-valsartan-with-amlodipine-in-hypertensive-patients-with-glucose-intolerance-22567 https://curecurrent.com/trials/post-authorisation-safety-study-of-samsca-tolvaptan-used-in-routine-medical-practice-22568 https://curecurrent.com/trials/the-effect-of-green-tea-extract-on-type-2-diabetes-with-hyperlipidemia-22569 https://curecurrent.com/trials/metformin-dipyridamole-interaction-trial-22570 https://curecurrent.com/trials/hypoglycemia-at-initiation-of-pump-therapy-in-children-with-type-1-diabetes-22571 https://curecurrent.com/trials/prevalence-of-hba1c-in-women-with-pcos-22572 https://curecurrent.com/trials/the-aging-endocrine-pancreas-characterization-of-the-entero-insular-axis-physiology-in-the-elderly-22573 https://curecurrent.com/trials/a-study-of-two-methods-for-determining-the-renal-threshold-for-glucose-in-patients-with-type-2-diabetes-mellitus-22574 https://curecurrent.com/trials/validation-of-algorithms-for-basal-insulin-rate-reductions-in-type-1-diabetic-patients-practising-physical-activity-22575 https://curecurrent.com/trials/tactile-massage-in-type-2-diabetes-22576 https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-sk3530-on-erectile-dysfunction-in-patients-with-diabetes-mellitus-22577 https://curecurrent.com/trials/avandia-amaryl-or-avandamet-compared-with-metformin-avalanche-study-22578 https://curecurrent.com/trials/electrolyte-and-fluid-disturbances-in-subarachnoid-hemorrhage-and-traumatic-brain-injury-22579 https://curecurrent.com/trials/cost-effectiveness-of-glargine-insulin-versus-nph-insulin-22580 https://curecurrent.com/trials/performance-study-to-test-the-glucomen-day-system-using-intravascular-and-subcutaneous-microdialysis-in-subjects-with-ty-22581 https://curecurrent.com/trials/protein-profile-of-immunoregulatory-factors-in-diabetic-cataract-22582 https://curecurrent.com/trials/non-enhanced-magnetic-resonance-angiography-of-diabetic-ischemic-lower-limbs-22583 https://curecurrent.com/trials/management-of-type-2-diabetic-patients-treated-with-insulin-during-the-ramadan-22584 https://curecurrent.com/trials/capsaicin-nanoparticle-in-patient-with-painful-diabetic-neuropathy-22585 https://curecurrent.com/trials/pilot-study-of-glycemic-control-in-diabetic-hemodialyzed-patients-22586 https://curecurrent.com/trials/insulin-lispro-6-days-versus-insulin-aspart-6-days-in-pump-use-22587 https://curecurrent.com/trials/rosuvastatin-prevent-contrast-induced-acute-kidney-injury-in-patients-with-diabetes-22588 https://curecurrent.com/trials/performance-of-a-tablet-based-workflow-and-decision-support-system-with-incorporated-software-algorithm-used-for-glycaem-22589 https://curecurrent.com/trials/melatonin-for-prevention-of-metabolic-side-effects-of-olanzapine-22590 https://curecurrent.com/trials/metformin-and-gestational-diabetes-in-high-risk-patients-a-rcts-22591 https://curecurrent.com/trials/vildagliptin-in-new-onset-diabetes-after-transplantation-22592 https://curecurrent.com/trials/exercise-training-in-patients-with-coronary-heart-disease-and-type-2-diabetes-22593 https://curecurrent.com/trials/insulins-glargine-and-glulisine-strategy-versus-premixed-insulin-strategy-a-comparative-study-22594 https://curecurrent.com/trials/nighttime-dosing-of-antihypertensive-drugs-in-type-2-diabetes-22595 https://curecurrent.com/trials/evaluation-of-the-effects-of-heating-or-massaging-or-vibrating-at-the-vicinity-of-the-insulin-delivery-site-22596 https://curecurrent.com/trials/use-of-intravitreal-ranibizumab-in-the-treatment-of-vitreous-hemorrhage-22597 https://curecurrent.com/trials/closing-the-loop-in-young-children-with-type-1-diabetes-22598 https://curecurrent.com/trials/gip-effects-at-insulin-induced-hypoglycemia-in-patients-with-type-2-diabetes-22599 https://curecurrent.com/trials/a-comparison-between-pupillometry-heart-rate-variability-and-metaiodobenzylguanidine-scintigraphy-for-the-diagnosis-of-e-22600 https://curecurrent.com/trials/a-study-of-the-effects-of-exercise-intensity-on-insulin-sensitivity-in-overweight-youth-22601 https://curecurrent.com/trials/study-comparing-efficacy-and-safety-of-amaryl-m-and-metformin-uptitraion-to-type-2-dm-22602 https://curecurrent.com/trials/efficacy-safety-study-of-amaryl-m-1-500-mg-twice-daily-versus-amaryl-4-mg-both-in-combination-with-lantus-in-type-2-diab-22603 https://curecurrent.com/trials/telephone-counselling-to-promote-physical-activity-in-diabetes-mellitus-people-22604 https://curecurrent.com/trials/open-label-study-of-tak-875-22605 https://curecurrent.com/trials/autologous-bone-marrow-stem-cell-transfer-in-patients-with-chronical-critical-limb-ischemia-and-diabetic-foot-22606 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-in-participants-with-type-2-diabetes-22607 https://curecurrent.com/trials/study-assessing-safety-and-efficacy-of-b-cure-laser-treating-diabetic-chronic-wounds-22608 https://curecurrent.com/trials/intensive-life-style-intervention-in-type-2-diabetes-patients-22609 https://curecurrent.com/trials/two-pieces-of-fruit-to-type-2-diabetics-22610 https://curecurrent.com/trials/treatment-use-of-generex-oral-lyn-in-patients-with-diabetes-22611 https://curecurrent.com/trials/genetic-markers-of-coronary-heart-disease-in-type-2-diabetes-22612 https://curecurrent.com/trials/pharmacokinetic-and-injection-site-toleration-of-biod-238-and-biod-250-compared-to-humalog-in-subjects-with-type-1-diabe-22613 https://curecurrent.com/trials/safety-and-efficacy-study-of-vitrase-for-clearance-of-severe-vitreous-hemorrhage-22614 https://curecurrent.com/trials/impairment-in-glucose-homeostasis-among-obese-adolescents-in-high-risk-diabetes-prone-population-jisr-az-zarqa-village-22615 https://curecurrent.com/trials/sex-specific-association-with-kidney-disease-22616 https://curecurrent.com/trials/metformin-and-longevity-genes-in-prediabetes-22617 https://curecurrent.com/trials/testing-the-effect-of-the-insupad-device-in-daily-life-conditions-22618 https://curecurrent.com/trials/the-effect-of-a-low-glycemic-index-diet-on-blood-sugar-control-in-pregnant-women-at-risk-for-gestational-diabetes-22619 https://curecurrent.com/trials/pharmacology-of-insulin-injected-with-jet-injection-in-diabetes-22620 https://curecurrent.com/trials/the-effect-of-continuous-sipping-of-a-glucose-solution-on-markers-of-oxidation-in-men-and-women-22621 https://curecurrent.com/trials/severe-insulin-resistance-in-patients-with-type-2-diabetes-22622 https://curecurrent.com/trials/progression-from-impaired-fasting-glucose-to-type-2-diabetes-mellitus-among-subjects-with-and-without-hypertension-in-pr-22623 https://curecurrent.com/trials/new-frontiers-on-bariatric-surgical-procedures-classical-bypass-for-type-2-diabetic-patients-with-obesity-grade-i-22624 https://curecurrent.com/trials/cardiopulmonary-fitness-lung-function-muscular-oxygen-saturation-and-quality-of-life-in-t1dm-22625 https://curecurrent.com/trials/prevalence-of-metabolic-syndrome-in-atahualpa-22626 https://curecurrent.com/trials/restoration-of-beta-cell-function-and-cardiovascular-parameters-in-relation-to-adipoinsular-and-enteroinsular-axes-after-22627 https://curecurrent.com/trials/effects-of-acute-intake-of-caffeinated-beverages-in-type-1-diabetes-22628 https://curecurrent.com/trials/glucose-metabolism-effects-of-vitamin-d-supplementation-in-prediabetes-22629 https://curecurrent.com/trials/intravitreal-bevacizumab-and-triamcinolone-associated-to-laser-photocoagulation-for-diabetic-macular-edema-ibeta-22630 https://curecurrent.com/trials/effects-of-n-3-polyunsaturated-fatty-acids-on-chylomicron-secretion-and-expression-of-genes-that-regulate-intestinal-lip-22631 https://curecurrent.com/trials/effect-of-diacylglycerol-oil-on-risk-factors-of-type-2-diabetes-and-complicating-disease-and-mechanism-22632 https://curecurrent.com/trials/effects-of-acarbose-on-endothelial-function-after-a-mixed-meal-in-newly-diagnosed-type-2-diabetes-22633 https://curecurrent.com/trials/the-effect-of-dbcare-a-food-supplement-on-diabetes-control-22634 https://curecurrent.com/trials/resistance-exercise-in-already-active-diabetic-individuals-readi-trial-22635 https://curecurrent.com/trials/assessment-of-efficacy-and-safety-of-insuman-comb-25-versus-novolin-30r-twice-daily-over-24-weeks-in-type-2-diabetes-pat-22636 https://curecurrent.com/trials/corticosteroids-and-hemoglobin-a1c-levels-in-diabetic-patients-with-copd-exacerbation-22637 https://curecurrent.com/trials/acetyl-l-carnitine-in-type-2-diabetes-22638 https://curecurrent.com/trials/best-timing-of-insulin-bolus-before-meals-of-different-contents-22639 https://curecurrent.com/trials/study-evaluating-eaa-090-in-adult-outpatients-with-neuropathic-pain-associated-with-diabetic-neuropathy-22640 https://curecurrent.com/trials/management-of-dyslipidemia-in-adult-type-2-diabetes-patients-in-india-22641 https://curecurrent.com/trials/preventing-renal-functional-abnormalities-with-calorie-restriction-in-subjects-with-abdominal-obesity-and-type-2-diabete-22642 https://curecurrent.com/trials/insulin-regimens-and-vascular-functions-22643 https://curecurrent.com/trials/predictors-of-future-type-2-diabetes-mellitus-in-circassians-minority-in-israel-22644 https://curecurrent.com/trials/a-comprehensive-longitudinal-cohort-study-in-type-2-diabetes-with-high-risk-of-cardiovascular-diseases-in-china-22645 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cj-30001-and-cj-30002-in-type-2-diabetes-mellitus-patients-22646 https://curecurrent.com/trials/cohort-study-in-type-2-diabetes-in-china-22647 https://curecurrent.com/trials/use-of-information-technology-in-the-prevention-of-diabetes-22648 https://curecurrent.com/trials/evaluation-of-effectiveness-of-treatment-paradigm-for-newly-diagnosed-type-2-diabetes-patients-in-china-22649 https://curecurrent.com/trials/efficacy-and-safety-of-ckd-501-versus-pioglitazone-when-added-to-metformin-22650 https://curecurrent.com/trials/nox-e36-first-in-human-fih-study-22651 https://curecurrent.com/trials/a-drug-interaction-study-of-slm0807-and-hkb0701-in-healthy-subjects-22652 https://curecurrent.com/trials/gestational-diabetes-the-prevention-22653 https://curecurrent.com/trials/effect-of-liraglutide-combined-with-short-term-csii-on-long-term-glycemic-remission-and-cell-function-22654 https://curecurrent.com/trials/nox-e36-multiple-ascending-dose-study-in-healthy-volunteers-and-patients-with-type-2-diabetes-mellitus-22655 https://curecurrent.com/trials/vildagliptin-versus-sitagliptin-differences-in-fasting-plasma-glucose-lowering-efficacy-22656 https://curecurrent.com/trials/vasopressin-versus-norepinephrine-for-the-management-of-shock-after-cardiac-surgery-22657 https://curecurrent.com/trials/regular-physical-exercise-extends-honeymoon-phase-in-type-1-diabetes-subjects-22658 https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-piperacillin-tazobactam-and-ampicillin-sulbactam-in-patients-with-diabetic-f-22659 https://curecurrent.com/trials/diurnal-triglyceridemia-in-relation-to-alcohol-intake-22660 https://curecurrent.com/trials/study-to-evaluate-the-effect-of-the-smart-care-diabetes-management-system-on-subjects-with-diabetes-22661 https://curecurrent.com/trials/cognitive-function-and-electrocardiogram-ecg-during-hypoglycemia-and-blockade-of-the-renin-angiotensin-system-22662 https://curecurrent.com/trials/comparison-of-glargine-and-oral-antidiabetic-drugs-oads-in-newly-diagnosed-type-2-diabetes-22663 https://curecurrent.com/trials/feasibility-study-integrated-sensor-and-infusion-set-trial-iii-22664 https://curecurrent.com/trials/feasibility-study-of-an-integrated-sensor-and-infusion-set-22665 https://curecurrent.com/trials/a-trial-to-investigate-efficacy-and-usability-of-published-best-practice-to-control-glycaemia-22666 https://curecurrent.com/trials/collection-of-performance-data-from-the-integrated-sensor-and-infusion-set-trial-4-22667 https://curecurrent.com/trials/changes-in-mitochondrial-uncoupling-protein-2-ucp2-messenger-rna-mrna-in-type-2-diabetes-t2dm-patients-22668 https://curecurrent.com/trials/interactive-studies-of-endstage-diabetic-dialysis-patients-22669 https://curecurrent.com/trials/effects-of-gamma-aminobutyric-acid-on-the-progression-of-new-onset-juvenile-type-1-diabetes-22670 https://curecurrent.com/trials/the-use-of-curexcelltm-in-a-community-setting-for-the-treatment-of-hard-to-heal-wounds-22671 https://curecurrent.com/trials/registry-of-diabetes-patients-in-a-large-health-maintenance-organization-in-israel-22672 https://curecurrent.com/trials/effectiveness-and-safety-of-treatment-of-insulin-glargine-in-type-2-diabetes-mellitus-following-glucagon-like-peptide-1-22673 https://curecurrent.com/trials/diurnal-variation-of-exogenous-peptides-endogenous-insulin-jurgita-ii-22674 https://curecurrent.com/trials/immunogenicity-study-of-wockhardt-s-insulin-lispro-lispro-mix-basal-bolus-regimen-in-type-1-diabetics-22675 https://curecurrent.com/trials/a-study-to-assess-the-effect-of-topical-recombinant-human-vascular-endothelial-growth-factor-for-induction-of-healing-of-22676 https://curecurrent.com/trials/diabetes-care-management-trial-of-telemetric-monitoring-22677 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-carisbamate-in-the-treatment-of-nerve-pain-in-diabetics-22678 https://curecurrent.com/trials/a-study-in-painful-diabetic-neuropathy-22679 https://curecurrent.com/trials/diet-insulin-sensitivity-and-the-brain-22680 https://curecurrent.com/trials/anterior-and-posterior-segment-vascular-changes-following-laser-and-anti-vascular-endothelial-growth-factor-vegf-treatme-22681 https://curecurrent.com/trials/diabetes-aerobic-and-resistance-exercise-dare-study-22682 https://curecurrent.com/trials/efficacy-of-behavioral-therapy-and-exercise-in-gestational-diabetes-mellitus-gdm-22683 https://curecurrent.com/trials/importance-of-meal-fat-content-and-gall-bladder-emptying-for-postprandial-glp-1-secretion-in-type-2-diabetes-patients-22684 https://curecurrent.com/trials/bile-acid-induced-glp-secretion-a-study-in-cholecystectomized-subjects-22685 https://curecurrent.com/trials/combination-of-olmesartan-and-ccb-or-low-dose-diuretics-in-high-risk-elderly-hypertensive-patients-study-colm-study-22686 https://curecurrent.com/trials/modulation-of-free-fatty-acids-in-heart-failure-patients-with-diabetes-effect-on-left-ventricular-function-22687 https://curecurrent.com/trials/peripheral-metabolic-effects-of-somatostatin-22688 https://curecurrent.com/trials/retinal-venous-pressure-and-et-1-in-patients-with-diabetes-mellitus-22689 https://curecurrent.com/trials/metabolic-effects-of-gastrointestinal-surgery-in-t2dm-22690 https://curecurrent.com/trials/the-effects-of-weight-loss-on-neuroadrenergic-function-22691 https://curecurrent.com/trials/prospective-study-phase-retinal-oxygen-saturation-blood-flow-vascular-function-and-high-resolution-morphometric-imaging-22692 https://curecurrent.com/trials/selective-retina-therapy-srt-for-clinically-significant-diabetic-macular-edema-22693 https://curecurrent.com/trials/slc2a1-variants-and-diabetic-nephropathy-22694 https://curecurrent.com/trials/pathophysiological-implications-of-the-incretin-hormones-in-maturity-onset-of-diabetes-of-the-young-mody-22695 https://curecurrent.com/trials/centralised-pan-algerian-survey-on-the-undertreatment-of-hypercholesterolemia-22696 https://curecurrent.com/trials/traditional-tibetan-medicine-for-patients-with-coronary-artery-disease-22697 https://curecurrent.com/trials/aqueous-flare-of-a-hydrophobic-acrylic-single-piece-open-loop-iol-with-modified-material-surface-properties-22698 https://curecurrent.com/trials/effects-of-food-cooking-on-diabetes-2-risk-factors-22699 https://curecurrent.com/trials/effect-of-nuts-vs-a-wheat-bran-muffin-in-type-2-diabetes-22700 https://curecurrent.com/trials/myo-inositol-d-chiro-inositol-and-d-chiro-myo-inositol-in-gestational-diabetes-22701 https://curecurrent.com/trials/comparison-of-a-basal-plus-one-insulin-regimen-with-a-biphasic-insulin-regimen-in-type-2-diabetes-patients-22702 https://curecurrent.com/trials/colchicine-for-diabetic-nephropathy-22703 https://curecurrent.com/trials/exercise-capability-and-training-effects-in-diabetic-patients-with-neuropathy-22704 https://curecurrent.com/trials/a-study-to-efficacy-and-safety-of-cwp-0403-in-type-2-diabetes-mellitus-patients-22705 https://curecurrent.com/trials/comparative-study-about-the-influence-of-diabetes-diatress-and-depression-on-treatment-adherence-in-chinese-type-2-diabe-22706 https://curecurrent.com/trials/efficacy-of-acarbose-on-intestinal-microbiome-and-incretins-of-type-2-diabetes-22707 https://curecurrent.com/trials/effects-of-physical-training-on-heart-rate-variability-and-exercise-capacity-in-diabetes-with-autonomic-neuropathy-22708 https://curecurrent.com/trials/intravitreal-long-acting-gas-in-the-prevention-of-early-postoperative-vitreous-hemorrhage-in-diabetic-vitrectomy-22709 https://curecurrent.com/trials/a-study-to-evaluate-the-blood-glucose-regulation-and-safety-of-ppb-r-203-02-based-noodle-versus-commercially-available-w-22710 https://curecurrent.com/trials/incidence-of-various-types-of-systemic-reactions-related-to-spinal-steroid-injection-a-prospective-study-22711 https://curecurrent.com/trials/evaluation-of-block-duration-in-type-2-diabetes-patients-22712 https://curecurrent.com/trials/metabolic-changes-in-prostate-cancer-patients-with-androgen-ablation-therapy-aat-22713 https://curecurrent.com/trials/optimized-strategy-for-diabetic-patients-with-critical-limb-ischemia-part-ii-dcli-ii-22714 https://curecurrent.com/trials/hypothalamic-function-before-and-after-bariatric-surgery-22715 https://curecurrent.com/trials/optimized-strategy-for-diabetic-patients-with-critical-limb-ischemia-part-i-22716 https://curecurrent.com/trials/a-multicenter-randomized-parallel-group-study-to-investigate-the-efficacy-of-a-combination-of-rosuvastatin-and-fenofibra-22717 https://curecurrent.com/trials/copper-study-complications-of-polycystic-ovary-syndrome-pcos-pregnancy-evaluating-risk-22718 https://curecurrent.com/trials/comparison-of-xience-prime-versus-resolute-integrity-in-diabetes-or-small-vessel-disease-22719 https://curecurrent.com/trials/bioequivalence-study-for-acarbose-metformin-fdc-22720 https://curecurrent.com/trials/apidra-children-adolescents-study-22721 https://curecurrent.com/trials/safety-and-efficacy-of-galvus-in-elderly-type-2-diabetes-patients-22722 https://curecurrent.com/trials/glucose-variability-with-dpp-4-inhibition-22723 https://curecurrent.com/trials/study-of-comparing-the-different-effect-of-dpp-4-inhibitors-and-sulfonylurea-by-using-biphase-hyperglycemic-clamp-22724 https://curecurrent.com/trials/tailored-antiplatelet-therapy-during-percutaneous-coronary-intervention-in-patients-with-diabetes-mellitus-22725 https://curecurrent.com/trials/efficacy-study-of-panax-ginseng-to-boost-antipsychotics-effects-in-schizophrenia-22726 https://curecurrent.com/trials/carotid-atherosclerosis-metformin-for-insulin-resistance-study-22727 https://curecurrent.com/trials/the-effects-of-exenatide-on-post-meal-sugar-peaks-and-vascular-health-in-obese-pre-diabetic-young-adults-22728 https://curecurrent.com/trials/intravitreal-ranibizumab-combined-with-panretinal-photocoagulation-in-patients-with-proliferative-diabetic-retinopathy-22729 https://curecurrent.com/trials/effects-of-sitagliptin-on-postprandial-lipemia-in-men-with-type-2-diabetes-22730 https://curecurrent.com/trials/hematopoietic-stem-cell-transplantation-in-type-1-diabetes-mellitus-22731 https://curecurrent.com/trials/autoimmune-diabetes-markers-of-the-disease-and-treatment-of-latent-autoimmune-diabetes-in-adults-lada-22732 https://curecurrent.com/trials/comparison-of-closed-loop-operation-after-morning-meal-with-and-without-carbohydrate-counting-22733 https://curecurrent.com/trials/health-effects-of-recreational-soccer-in-type-2-diabetic-men-22734 https://curecurrent.com/trials/one-touch-verio-iq-european-clinical-outcomes-study-22735 https://curecurrent.com/trials/ramipril-and-clopidogrel-in-oxidative-stress-vascular-inflammation-and-endothelial-dysfunction-in-type-2-diabetes-and-di-22736 https://curecurrent.com/trials/hypoglycemia-and-weight-related-quality-of-life-in-patients-with-diabetes-mellitus-type-2-on-sulfonylurea-derivatives-22737 https://curecurrent.com/trials/lifestyle-intervention-in-obese-non-diabetic-adults-with-a-family-history-of-diabetes-22738 https://curecurrent.com/trials/how-improvement-in-control-of-diabetes-influences-the-production-of-a-hormone-produced-in-the-gut-which-improves-the-rel-22739 https://curecurrent.com/trials/combined-nutritional-and-exercise-strategies-to-reduce-liver-fat-content-in-patients-with-type-2-diabetes-22740 https://curecurrent.com/trials/japanese-phase-1-multiple-ascending-dose-study-22741 https://curecurrent.com/trials/evaluation-of-scout-ds-device-in-the-diagnosis-of-diabetes-mellitus-22742 https://curecurrent.com/trials/effect-of-nph-insulin-insulin-detemir-and-insulin-glargine-on-gh-igf-igfbp-axis-22743 https://curecurrent.com/trials/lancing-device-comparison-study-22744 https://curecurrent.com/trials/the-impact-of-omega-3-supplementation-on-gene-expression-in-type-2-diabetics-22745 https://curecurrent.com/trials/biobehavioral-bases-management-of-type-2-diabetes-22746 https://curecurrent.com/trials/feasibility-study-of-a-portable-artificial-pancreas-system-in-type-1-diabetes-mellitus-t1dm-montpellier-22747 https://curecurrent.com/trials/pilot-study-1-of-outpatient-control-to-range-system-and-monitoring-testing-22748 https://curecurrent.com/trials/prospective-observatonal-study-for-effect-of-duodenojejunal-bypass-and-gastric-bypass-on-t2dm-patients-22749 https://curecurrent.com/trials/mode-of-action-of-topiramate-in-the-treatment-of-obese-patients-with-and-without-type-2-diabetes-mellitus-22750 https://curecurrent.com/trials/lifestyle-intervention-with-an-interactive-video-game-for-type-2-diabetes-patients-22751 https://curecurrent.com/trials/type-2-diabetes-mellitus-and-atherosclerosis-22752 https://curecurrent.com/trials/nutritional-prevention-pilot-trial-for-type-1-diabetes-22753 https://curecurrent.com/trials/safety-and-efficacy-of-aripiprazole-and-ziprasidone-among-schizophrenic-patients-with-metabolic-syndrome-22754 https://curecurrent.com/trials/10-prescriptions-an-hour-group-treatment-and-physical-activity-referral-in-a-primary-health-care-setting-22755 https://curecurrent.com/trials/comparative-bioavailability-gender-effect-single-and-multiple-ascending-dose-safety-and-pharmacokinetic-study-of-gft505-22756 https://curecurrent.com/trials/renal-sympathetic-denervation-as-secondary-prevention-for-patients-after-percutaneous-coronary-intervention-22757 https://curecurrent.com/trials/evaluate-efficacy-safety-and-tolerability-of-azd1656-as-add-on-treatment-to-metformin-in-type-2-diabetes-mellitus-td2m-p-22758 https://curecurrent.com/trials/health-assessment-patient-treatment-satisfaction-and-quality-of-life-in-insulin-naive-type-2-diabetes-patients-22759 https://curecurrent.com/trials/study-to-evaluate-the-effects-of-colesevelam-on-insulin-sensitivity-and-ss-cell-function-in-subjects-with-impaired-fasti-22760 https://curecurrent.com/trials/exercise-testing-to-screen-for-unknown-coronary-artery-disease-in-diabetic-patients-does-it-contribute-to-a-risk-reducti-22761 https://curecurrent.com/trials/arterial-wall-calcium-load-in-pseudoxanthoma-elasticum-22762 https://curecurrent.com/trials/assessing-continuous-non-invasive-blood-glucose-sensor-physical-logic-ag-22763 https://curecurrent.com/trials/diacon-overnight-closed-loop-glucose-control-study-22764 https://curecurrent.com/trials/umbilical-mesenchymal-stem-cells-and-mononuclear-cells-infusion-in-type-1-diabetes-mellitus-22765 https://curecurrent.com/trials/evaluation-of-effects-of-exercise-training-and-arb-in-dm-patients-22766 https://curecurrent.com/trials/resistance-training-in-diabetic-elder-patients-22767 https://curecurrent.com/trials/adalat-xl-vs-diltiazem-on-proteinuria-and-blood-pressure-in-hypertensive-diabetic-patients-22768 https://curecurrent.com/trials/improvement-of-a-physically-active-lifestyle-22769 https://curecurrent.com/trials/stage-based-exercise-promotion-study-22770 https://curecurrent.com/trials/increasing-vitamin-intake-and-physical-activity-22771 https://curecurrent.com/trials/online-program-assisting-lifestyle-changes-asterix-1-0-obelix-2-0-22772 https://curecurrent.com/trials/achieving-normal-glucose-in-hospital-settings-22773 https://curecurrent.com/trials/study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22774 https://curecurrent.com/trials/efficacy-and-safety-study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22775 https://curecurrent.com/trials/safety-study-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22776 https://curecurrent.com/trials/efficacy-of-tak-559-in-treating-subjects-with-type-2-diabetes-mellitus-22777 https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-of-grc-17536-in-patients-with-painful-diabetic-neuropathy-painful-extremities-due-22778 https://curecurrent.com/trials/prevention-of-renal-complications-of-diabetes-with-thiamine-22779 https://curecurrent.com/trials/beneficial-effects-of-korean-traditional-diets-in-subjects-with-hypertension-and-type-2-diabetes-22780 https://curecurrent.com/trials/double-blind-comparative-study-of-tak-875-22781 https://curecurrent.com/trials/effect-of-taurine-on-glycemic-control-in-type-i-and-type-ii-diabetic-patients-22782 https://curecurrent.com/trials/jordan-diabetes-microclinic-project-22783 https://curecurrent.com/trials/efficacy-and-safety-of-alprostadil-prevent-contrast-induced-nephropathy-22784 https://curecurrent.com/trials/safety-and-efficacy-of-mecobalamin-injection-in-peripheral-neuropathies-patients-study-jgazsy091109-22785 https://curecurrent.com/trials/clinical-trial-for-the-treatment-of-diabetic-foot-ulcers-using-a-nitric-oxide-releasing-patch-pathon-22786 https://curecurrent.com/trials/diabetic-retinopathy-sulodexide-study-22787 https://curecurrent.com/trials/diagnosis-and-therapy-of-vulnerable-atherosclerotic-plaque-22788 https://curecurrent.com/trials/metabolic-effects-of-treatment-in-patients-with-recently-diagnosed-type-2-diabetes-22789 https://curecurrent.com/trials/nitrate-and-exercise-induced-cardiac-troponin-t-in-type-2-diabetes-22790 https://curecurrent.com/trials/weight-gain-eating-patterns-and-development-of-body-composition-during-initiation-of-basal-insulin-therapy-in-patients-w-22791 https://curecurrent.com/trials/ss-cell-function-and-glycemic-control-in-newly-diagnosed-type-2-diabetic-patients-with-moderate-hyperglycemia-22792 https://curecurrent.com/trials/neurotrophic-factors-in-cerebrospinal-fluid-in-diabetic-patients-with-polyneuropathy-22793 https://curecurrent.com/trials/tolvaptan-for-hyponatremia-in-cirrhotic-patients-with-ascites-22794 https://curecurrent.com/trials/a-clinical-safety-and-efficacy-comparison-of-nevanac-0-1-to-vehicle-after-cataract-surgery-in-diabetic-retinopathy-patie-22795 https://curecurrent.com/trials/effect-of-different-plasma-insulin-levels-on-the-accuracy-of-continuous-subcutaneous-glucose-monitoring-22796 https://curecurrent.com/trials/exercise-and-glycemic-control-in-type-2-diabetes-22797 https://curecurrent.com/trials/mobile-phone-applications-and-quality-of-life-22798 https://curecurrent.com/trials/use-of-computers-to-prevent-metabolic-syndrome-22799 https://curecurrent.com/trials/device-guided-breathing-exercises-on-blood-pressure-in-diabetic-patients-22800 https://curecurrent.com/trials/be-study-of-metformin-gsk-850mg-22801 https://curecurrent.com/trials/effects-of-nateglinide-on-postprandial-glucose-excursion-by-restoring-early-phase-insulin-secretion-22802 https://curecurrent.com/trials/be-study-of-metformin-gsk-1000mg-22803 https://curecurrent.com/trials/dpp-iv-inhibitors-underlying-mechanism-of-cancer-in-diabetic-patients-22804 https://curecurrent.com/trials/the-effects-of-soy-isoflavones-to-improve-the-metabolism-of-glucose-and-lipids-22805 https://curecurrent.com/trials/nir-and-multifrequent-impedance-spectroscopy-on-the-skin-in-type-1-diabetes-22806 https://curecurrent.com/trials/the-relationship-between-vascular-adhesion-protein-1-and-diabetic-cardiovascular-autonomic-neuropathy-22807 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-brl-49653c-in-non-insulin-dependent-diabetes-22808 https://curecurrent.com/trials/regulation-of-tissue-lipolysis-by-insulin-in-type-2-diabetes-22809 https://curecurrent.com/trials/prevention-of-contrast-induced-nephropathy-by-erythropoietin-22810 https://curecurrent.com/trials/vitamin-d-supplementation-and-regulatory-foxp3-t-cells-in-the-gut-22811 https://curecurrent.com/trials/adding-sitagliptin-or-pioglitazone-to-type-2-diabetes-mellitus-insufficiently-controlled-with-metformin-and-sulfonylurea-22812 https://curecurrent.com/trials/vitamin-d-inadequacy-is-associated-with-incidence-of-type-2-diabetes-22813 https://curecurrent.com/trials/fgf-23-and-endothelial-dysfunction-in-diabetic-proteinuric-patients-22814 https://curecurrent.com/trials/the-acute-effect-of-malt-extract-versus-sucrose-on-the-response-of-glucose-and-insulin-subjective-appetite-sensations-an-22815 https://curecurrent.com/trials/impact-of-objective-sleep-duration-on-blood-glucose-control-in-type-1-diabetes-adult-patients-22816 https://curecurrent.com/trials/activity-and-metformin-intervention-in-obese-adolescents-22817 https://curecurrent.com/trials/physical-and-chemical-study-of-atherosclerosis-mechanisms-22818 https://curecurrent.com/trials/health2006-an-observational-study-of-cardiovascular-disease-diabetes-asthma-and-allergy-22819 https://curecurrent.com/trials/lifestyle-intervention-in-a-general-population-for-prevention-of-ischaemic-heart-disease-22820 https://curecurrent.com/trials/reduction-of-plantar-pressure-in-neuropathic-diabetic-foot-patients-using-insoles-with-removable-pegs-design-22821 https://curecurrent.com/trials/the-effect-of-a-lipoic-acid-ala-on-fatty-acid-induced-impairment-of-glucose-stimulated-insulin-secretion-22822 https://curecurrent.com/trials/dose-ranging-study-of-the-effects-of-alpha-lipoic-acid-on-oxidative-stress-22823 https://curecurrent.com/trials/tissue-distribution-of-f18-fdg-labelled-autologous-bone-marrow-derived-stem-cells-in-patients-with-type-2-dm-22824 https://curecurrent.com/trials/anti-inflammatory-effects-of-pioglitazone-22825 https://curecurrent.com/trials/combined-triple-therapy-in-diabetic-retinopathy-drp-22826 https://curecurrent.com/trials/interventions-to-prevent-adolescents-with-type-1-diabetes-from-long-term-complications-22827 https://curecurrent.com/trials/vildagliptin-and-the-glucagon-response-to-hypoglycemia-in-type-1-diabetes-22828 https://curecurrent.com/trials/identification-of-the-region-of-vitamin-d-responsiveness-22829 https://curecurrent.com/trials/sitagliptin-in-renal-transplant-recipients-22830 https://curecurrent.com/trials/effects-of-antioxidants-and-b-vitamins-supplements-on-inflammation-in-obese-diabetic-patients-22831 https://curecurrent.com/trials/bromelain-and-cardiovascular-risk-factors-in-diabetes-22832 https://curecurrent.com/trials/pilot-study-with-gft505-80mg-in-patients-with-insulin-resistance-and-abdominal-obesity-22833 https://curecurrent.com/trials/quantification-of-rising-the-osmotic-pressure-in-diabetic-intraretinal-fluid-accumulation-diabetic-macular-oedema-22834 https://curecurrent.com/trials/endothelial-and-metabolic-effects-of-glucagon-like-peptide-1-glp-1-in-coronary-circulation-in-patients-with-type-2-diabe-22835 https://curecurrent.com/trials/the-metabolic-effects-of-acute-hyperglycemia-in-patients-with-type-2-diabetes-22836 https://curecurrent.com/trials/effect-of-pharmacological-anti-lipolysis-on-ffa-and-vldl-tg-metabolism-before-and-during-exercise-22837 https://curecurrent.com/trials/a-randomized-controlled-trial-comparing-medical-and-medical-surgical-treatment-in-diabetic-foot-osteomyelitis-22838 https://curecurrent.com/trials/pharmaceutical-care-of-ambulatory-elderly-diabetes-patients-22839 https://curecurrent.com/trials/effect-of-genistein-in-women-with-metabolic-syndrome-22840 https://curecurrent.com/trials/evaluation-of-the-effects-of-heating-the-vicinity-of-the-insulin-delivery-site-by-the-insupatch-device-during-daily-life-22841 https://curecurrent.com/trials/improving-diabetes-by-reconstruction-methods-in-gastric-cancer-patients-with-diabetes-mellitus-22842 https://curecurrent.com/trials/normalization-of-fasting-glucose-and-the-incidence-of-restenosis-after-peripheral-angioplasty-22843 https://curecurrent.com/trials/metabolic-activation-with-almased-for-type-2-diabetes-patients-22844 https://curecurrent.com/trials/a-cohort-study-of-incretin-based-therapy-combined-with-insulin-in-type-2-diabetic-patients-for-5-years-22845 https://curecurrent.com/trials/polydeoxyribonucleotide-placentex-mastelli-pdrn-for-the-treatment-of-diabetic-ulcers-22846 https://curecurrent.com/trials/study-of-maggot-therapy-in-diabetic-foot-ulcers-22847 https://curecurrent.com/trials/nutritional-intervention-with-moderately-high-protein-low-glycemic-load-products-in-type-2-diabetes-patients-22848 https://curecurrent.com/trials/clinical-and-pathophysiological-description-of-ocular-ischemic-syndrome-22849 https://curecurrent.com/trials/safety-and-efficacy-study-of-herbal-supplements-in-prediabetic-and-mild-to-moderate-hyperlipidemic-patients-22850 https://curecurrent.com/trials/ileal-interposition-with-sleeve-gastrectomy-for-control-of-diabetes-22851 https://curecurrent.com/trials/patient-based-strategy-to-reduce-errors-in-diabetes-care-22852 https://curecurrent.com/trials/vitamin-d-and-staphylococcus-aureus-in-the-diabetes-study-22853 https://curecurrent.com/trials/effects-of-advanced-glycation-endproducts-on-satiety-and-inflammation-22854 https://curecurrent.com/trials/pilot-study-to-evaluate-magnetic-marker-imaging-on-diabetic-polyneuropathy-and-gastroparesis-22855 https://curecurrent.com/trials/insulin-analogues-and-severe-hypoglycaemia-22856 https://curecurrent.com/trials/the-effect-of-nexium-and-probiotics-on-insulin-secretion-and-cardiovascular-risk-factors-in-patients-with-type-2-diabete-22857 https://curecurrent.com/trials/effects-of-resveratrol-in-patients-with-type-2-diabetes-22858 https://curecurrent.com/trials/safety-and-efficacy-of-long-limb-roux-en-y-reconstruction-22859 https://curecurrent.com/trials/anti-interleukin-1-in-diabetes-action-22860 https://curecurrent.com/trials/bolus-calculator-and-wireless-communication-with-blood-glucose-meter-in-management-of-type-1-diabetes-mellitus-t1dm-22861 https://curecurrent.com/trials/applications-site-reactions-after-injection-of-insulin-detemir-and-saline-in-subjects-with-diabetes-22862 https://curecurrent.com/trials/fit-for-kids-copenhagen-22863 https://curecurrent.com/trials/intensive-insulin-glulisine-therapy-in-patients-with-type-2-diabetes-inadequately-controlled-with-basal-insulin-and-oral-22864 https://curecurrent.com/trials/new-strategies-for-postprandial-glycemic-control-using-insulin-pump-therapy-22865 https://curecurrent.com/trials/effects-of-spironolactone-combination-therapy-on-proteinuria-kidney-function-and-blood-pressure-22866 https://curecurrent.com/trials/japan-dose-regimen-study-of-azd1656-in-japanese-type-2-diabetes-mellitus-patients-22867 https://curecurrent.com/trials/compare-the-compliance-of-patients-treated-with-once-daily-od-or-twice-daily-bid-glimepiride-and-metformin-fixed-combina-22868 https://curecurrent.com/trials/effect-of-low-glycaemic-index-diet-on-blood-glucose-control-in-chinese-type-2-diabetic-patients-22869 https://curecurrent.com/trials/galvus-on-met-phase-4-study-study-to-evaluate-the-efficacy-and-safety-of-early-combination-of-vildagliptin-and-metformin-22870 https://curecurrent.com/trials/the-association-between-monocyte-subsets-and-coronary-collateral-development-in-diabetes-mellitus-22871 https://curecurrent.com/trials/mechanisms-of-glucose-counterregulation-in-pancreatic-islet-transplantation-22872 https://curecurrent.com/trials/lantus-versus-nph-comparison-in-insulin-naive-people-not-adequately-controlled-with-at-least-one-oral-anti-diabetics-oad-22873 https://curecurrent.com/trials/a-study-on-traditional-chinese-medicine-tcm-comprehensive-protocol-of-prevention-and-control-in-diabetic-retinopathy-22874 https://curecurrent.com/trials/treatment-with-sitagliptin-in-non-obese-japanese-patients-with-type-2-diabetes-mellitus-22875 https://curecurrent.com/trials/a-practice-nurse-addressed-intervention-to-improve-type-2-diabetes-care-22876 https://curecurrent.com/trials/a-pk-pd-study-of-psn821-in-type-2-diabetes-patients-t2dm-22877 https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-sulfonylurea-or-metformin-in-participants-with-type-2-diab-22878 https://curecurrent.com/trials/effects-of-genistein-in-postmenopausal-women-with-metabolic-syndrome-22879 https://curecurrent.com/trials/the-effects-of-insulin-detemir-and-gliclazide-mr-treatments-on-endothelial-functions-in-patients-with-type-2-diabetes-22880 https://curecurrent.com/trials/effects-of-vitamin-d-and-calcium-supplementation-on-inflammatory-biomarkers-and-adypocytokines-in-diabetic-patients-22881 https://curecurrent.com/trials/a-study-of-minirin-melt-in-japanese-patients-with-central-diabetes-insipidus-cdi-22882 https://curecurrent.com/trials/safety-study-of-intranasal-insulin-in-type-1-diabetes-and-diabetic-peripheral-neuropathy-22883 https://curecurrent.com/trials/saxagliptin-triple-oral-therapy-22884 https://curecurrent.com/trials/diabetes-prevention-in-prediabetic-patients-22885 https://curecurrent.com/trials/evaluation-of-intermediate-care-clinics-for-diabetes-22886 https://curecurrent.com/trials/efficacy-and-safety-of-glimepiride-as-oral-anti-diabetic-oad-initiation-mono-therapy-in-chinese-type-2-diabetes-mellitus-22887 https://curecurrent.com/trials/effect-of-fish-oil-on-insulin-sensitivity-22888 https://curecurrent.com/trials/efficacy-and-safety-of-dlbs3233-in-prediabetic-patients-22889 https://curecurrent.com/trials/practice-based-nutrition-intervention-22890 https://curecurrent.com/trials/effect-of-flavanol-rich-cocoa-on-peripheral-and-cerebral-blood-flow-in-type-2-diabetes-22891 https://curecurrent.com/trials/a-study-on-the-effects-of-ranolazine-on-exercise-duration-in-subjects-with-chronic-stable-angina-and-coronary-artery-dis-22892 https://curecurrent.com/trials/peking-and-rotterdam-on-mission-to-reduce-coronary-artery-disease-22893 https://curecurrent.com/trials/multi-day-3-in-patient-evaluation-of-intradermal-versus-subcutaneous-basal-and-bolus-insulin-infusion-22894 https://curecurrent.com/trials/intensity-of-exercise-and-glucose-metabolism-22895 https://curecurrent.com/trials/longitudinal-measures-of-leptin-in-pregnant-women-who-developed-preeclampsia-22896 https://curecurrent.com/trials/safety-and-efficacy-of-insulin-aspart-in-type-2-diabetes-22897 https://curecurrent.com/trials/neurovascular-coupling-in-patients-with-early-stage-diabetes-retinopathy-22898 https://curecurrent.com/trials/impact-of-acarbose-on-abnormal-glucose-regulation-in-patients-with-coronary-artery-disease-aaa-trial-22899 https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-the-use-of-ozone-versus-sunflower-oil-in-treating-diabetic-foot-22900 https://curecurrent.com/trials/test-of-the-efficacy-and-safety-of-insulin-glulisine-injected-subcutaneously-in-patients-with-type-1-diabetes-mellitus-22901 https://curecurrent.com/trials/insulin-glargine-lantus-vs-sulfonylurea-su-for-beta-cell-function-beta-study-22902 https://curecurrent.com/trials/complementary-and-integrative-therapy-for-diabetic-neuropathy-22903 https://curecurrent.com/trials/long-term-effects-of-gestational-diabetes-mellitus-in-a-population-of-parous-women-22904 https://curecurrent.com/trials/propofol-cardioprotection-for-type-ii-diabetics-22905 https://curecurrent.com/trials/a-randomized-clinical-trial-of-megestrol-acetate-as-an-appetite-stimulant-in-malnourished-children-with-cancer-22906 https://curecurrent.com/trials/alemtuzumab-induction-in-islet-transplantation-22907 https://curecurrent.com/trials/dextromethorphan-amantadine-and-glucose-homeostasis-in-diabetes-subjects-22908 https://curecurrent.com/trials/skin-samples-of-diabetic-patients-and-healthy-volunteers-collection-22909 https://curecurrent.com/trials/effect-of-pioglitazone-on-ambulatory-blood-pressure-22910 https://curecurrent.com/trials/early-diagnosis-of-diabetes-mellitus-in-patients-with-cystic-fibrosis-22911 https://curecurrent.com/trials/the-effects-of-hypolipemic-and-antidiabetic-treatment-on-cytokines-22912 https://curecurrent.com/trials/role-of-nutrition-and-maternal-genetics-on-the-programming-of-development-of-fetal-adipose-tissue-22913 https://curecurrent.com/trials/evaluation-of-scout-ds-device-in-the-diagnosis-of-diabetes-22914 https://curecurrent.com/trials/multicentre-study-to-investigate-the-performance-of-the-padd-device-in-the-assessment-of-peripheral-arterial-disease-22915 https://curecurrent.com/trials/endothelial-dysfunction-and-diabetes-22916 https://curecurrent.com/trials/safety-acceptability-and-efficacy-of-a-long-term-intervention-with-a-diabetes-specific-low-carbohydrate-high-mono-unsatu-22917 https://curecurrent.com/trials/sitagliptin-prophylaxis-for-glucocorticoid-induced-impairment-of-glucose-metabolism-in-males-with-the-metabolic-syndrome-22918 https://curecurrent.com/trials/frequency-modulated-neural-stimulation-frems-in-symptomatic-diabetic-neuropathy-22919 https://curecurrent.com/trials/closing-the-loop-in-adolescents-during-non-compliance-behaviours-22920 https://curecurrent.com/trials/closing-the-loop-for-36-hours-in-adolescents-with-type-1-diabetes-evaluation-of-reduced-meal-bolusing-22921 https://curecurrent.com/trials/the-cost-effectiveness-of-screening-for-diabetic-retinopathy-in-hong-kong-22922 https://curecurrent.com/trials/adolescent-fitness-assessment-program-22923 https://curecurrent.com/trials/automated-overnight-closed-loop-glucose-control-in-young-people-with-type-1-diabetes-22924 https://curecurrent.com/trials/comparison-of-two-insulin-regimens-in-optimally-controlled-patients-with-dm2-22925 https://curecurrent.com/trials/evaluating-the-renoprotective-effect-of-milk-thistle-extract-on-patients-with-type-ii-diabetic-nephropathy-22926 https://curecurrent.com/trials/endothelial-function-as-a-marker-for-blood-pressure-control-among-hypertensive-diabetic-patients-22927 https://curecurrent.com/trials/comparison-of-hypoglycaemic-regimens-during-ramadan-fasting-in-type-2-diabetes-22928 https://curecurrent.com/trials/the-effect-of-rosuvastatin-in-diabetic-polyneuropathy-a-phase-iia-randomized-double-blind-placebo-controlled-study-22929 https://curecurrent.com/trials/effect-of-ezetimibe-or-simvastatin-or-both-on-low-densitiy-lipoprotein-subfractions-in-patients-with-type-2-diabetes-22930 https://curecurrent.com/trials/nitric-oxide-no-activity-and-diabetic-nephropathy-22931 https://curecurrent.com/trials/an-investigation-into-bone-micro-architecture-in-women-with-type-2-diabetes-22932 https://curecurrent.com/trials/glibenclamide-dose-to-be-titrated-from-starting-dose-of-5mg-om-plus-rosiglitazone-4mg-om-increased-to-8mg-om-after-6-mon-22933 https://curecurrent.com/trials/effect-of-consuming-beans-for-one-month-on-blood-lipids-satiety-intake-regulation-and-body-weight-22934 https://curecurrent.com/trials/yellow-pea-protein-and-fibre-and-short-term-food-intake-22935 https://curecurrent.com/trials/yellow-pea-fractions-and-short-term-food-intake-subjective-appetite-and-glycemic-response-22936 https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22937 https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22938 https://curecurrent.com/trials/mk-0431-ono-5435-phase-iii-clinical-trial-insulin-add-on-study-for-patients-with-type-2-diabetes-mellitus-22939 https://curecurrent.com/trials/isovolumetric-and-isocaloric-preloads-of-various-types-of-milk-on-food-intake-subjective-appetite-and-glycemic-response-22940 https://curecurrent.com/trials/a-first-in-human-single-dose-safety-and-tolerability-study-of-mkc253-inhalation-powder-in-healthy-adult-males-22941 https://curecurrent.com/trials/a-study-designed-to-determine-the-safety-and-pharmacological-response-ofmkc253-inhalation-powder-in-adults-with-type-2-d-22942 https://curecurrent.com/trials/a-study-designed-to-determine-if-the-pharmacokinetic-disposition-of-inhaled-insulin-exposure-is-the-same-for-asthmatics-22943 https://curecurrent.com/trials/a-study-designed-to-determine-if-the-drugs-albuterol-salbutamol-and-fluticasone-have-an-effect-on-the-pharmacokinetics-o-22944 https://curecurrent.com/trials/pilot-study-of-ono-5129-in-patients-with-type-2-diabetes-mellitus-22945 https://curecurrent.com/trials/controlled-study-of-mk-0431-ono-5435-in-patients-with-type-2-diabetes-mellitus-22946 https://curecurrent.com/trials/validating-non-invasive-measurements-of-central-blood-pressure-in-type-2-diabetic-patients-22947 https://curecurrent.com/trials/glycemic-response-to-momordica-charantia-in-type-2-diabetes-22948 https://curecurrent.com/trials/aspirin-twice-daily-in-diabetic-patients-with-coronary-artery-disease-22949 https://curecurrent.com/trials/human-menstrual-blood-derived-mesenchymal-stem-cells-transplantation-in-treating-type-1-diabetic-patients-22950 https://curecurrent.com/trials/role-of-pioglitazone-and-berberine-in-treatment-of-non-alcoholic-fatty-liver-disease-22951 https://curecurrent.com/trials/treatment-satisfaction-of-insulin-glargine-plus-insulin-apidra-compared-with-nph-insulin-plus-insulin-apidra-in-recently-22952 https://curecurrent.com/trials/the-glycemic-response-elicited-by-beta-glucans-of-different-physical-properties-and-form-22953 https://curecurrent.com/trials/in-patient-study-in-patients-with-type-2-diabetes-mellitus-22954 https://curecurrent.com/trials/screening-epidemiological-program-on-compensation-evaluation-of-diabetes-mellitus-type-2-dmt2-patients-on-oral-anti-diab-22955 https://curecurrent.com/trials/drug-interactions-from-simultaneous-administration-of-metformin-and-gsk189075-to-subjects-with-type-2-diabetes-22956 https://curecurrent.com/trials/a-study-of-rosiglitazone-plus-insulin-to-treat-type-2-diabetes-mellitus-patients-22957 https://curecurrent.com/trials/a-study-on-the-effect-of-2-pen-devices-on-hba1c-22958 https://curecurrent.com/trials/impact-of-liraglutide-on-sensory-perception-sensory-specific-satiety-liking-and-wanting-in-type-2-diabetic-patients-22959 https://curecurrent.com/trials/a-study-to-to-assess-the-effect-of-dapagliflozin-when-administered-once-a-day-versus-twice-a-day-on-blood-glucose-22960 https://curecurrent.com/trials/study-to-assess-the-effect-of-food-on-combination-dapagliflozin-metformin-tablet-in-healthy-volunteers-22961 https://curecurrent.com/trials/eplerenone-ace-inhibition-and-albuminuria-22962 https://curecurrent.com/trials/effect-of-dipeptidyl-peptidase-iv-after-diets-in-n-ive-type-2-diabetic-patients-22963 https://curecurrent.com/trials/a-first-in-human-study-of-ly2409021-in-healthy-participants-and-participants-with-type-2-diabetes-22964 https://curecurrent.com/trials/induced-wound-healing-by-application-of-expanded-bone-marrow-stem-cells-in-diabetic-patients-with-critical-limb-ischemia-22965 https://curecurrent.com/trials/a-study-of-multiple-increasing-doses-of-ly2409021-in-participants-with-type-2-diabetes-22966 https://curecurrent.com/trials/a-lifestyle-and-combination-medication-therapy-diabetes-prevention-study-22967 https://curecurrent.com/trials/diabetes-risk-evaluation-and-management-tele-monitoring-study-dream-tel-22968 https://curecurrent.com/trials/efficacy-and-safety-study-of-syr-619-in-treating-subjects-with-type-2-diabetes-mellitus-22969 https://curecurrent.com/trials/safety-and-tolerability-of-pioglitazone-azilsartan-in-subjects-with-type-2-diabetes-22970 https://curecurrent.com/trials/phase-3-trial-to-evaluate-the-efficacy-and-safety-of-lc15-0444-in-patients-with-type-2-diabetes-22971 https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-lc15-0444-compared-with-sitagliptin-added-to-ongoing-metformin-th-22972 https://curecurrent.com/trials/hair-cortisol-and-testosterone-levels-in-patients-with-and-without-acute-myocardial-infarction-mi-22973 https://curecurrent.com/trials/study-of-the-safety-and-biologic-activity-of-xoma-052-in-subjects-with-type-2-diabetes-mellitus-22974 https://curecurrent.com/trials/diabetes-risk-evaluation-and-microalbuminuria-in-saskatchewan-first-nations-peoples-22975 https://curecurrent.com/trials/identifying-therapeutic-factors-in-an-8-week-30-hour-mindfulness-based-stress-reduction-mbsr-program-22976 https://curecurrent.com/trials/improving-the-management-of-obesity-in-primary-care-practice-the-power-up-trial-22977 https://curecurrent.com/trials/a-retrospective-study-of-cardiovascular-events-related-to-the-use-of-glucose-lowering-drug-treatment-in-primary-care-22978 https://curecurrent.com/trials/postprandial-insulin-secretion-oxidative-stress-and-gastrointestinal-peptides-in-patients-with-type-2-diabetes-versus-he-22979 https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-study-to-evaluate-the-effect-of-roflumilast-on-endothelial-function-in-patien-22980 https://curecurrent.com/trials/effects-of-nateglinide-vs-acarbose-on-postprandial-glucose-fluctuation-dyslipidemia-and-inflammatory-factors-22981 https://curecurrent.com/trials/the-clinical-and-economic-impacts-of-e-heath-on-diabetes-22982 https://curecurrent.com/trials/comparison-of-metformin-and-pioglitazone-effects-on-adipokines-concentrations-in-newly-diagnosed-type-2-diabetes-patient-22983 https://curecurrent.com/trials/the-effect-of-real-time-continuous-glucose-monitoring-on-severe-complications-to-pregnancy-in-women-with-diabetes-22984 https://curecurrent.com/trials/efficacy-and-safety-study-of-topical-capsaicin-in-painful-diabetic-neuropathy-22985 https://curecurrent.com/trials/trial-of-different-dosages-ge-gen-qin-lian-decoction-in-the-treatment-of-type-2-diabetes-22986 https://curecurrent.com/trials/healing-profile-of-titanium-dental-implants-placed-in-patients-with-diabetes-22987 https://curecurrent.com/trials/treatment-satisfaction-of-using-omnipod-system-compared-with-conventional-insulin-pump-in-adults-with-type-1-diabetes-22988 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-insulin-in-patients-with-type-2-diabetes-22989 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-metformin-in-drug-naive-patients-with-type-2-diabetes-22990 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-patients-with-type-2-diabetes-with-hba1c-9-11-22991 https://curecurrent.com/trials/a-study-to-assess-the-effects-of-dpp-4-inhibition-on-insulin-sensitivity-in-type-2-diabetes-22992 https://curecurrent.com/trials/multiple-ascending-dose-trial-of-byk324677-in-healthy-volunteers-22993 https://curecurrent.com/trials/a-lifestyle-change-program-to-prevent-type-2-diabetes-22994 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-placebo-in-patients-with-type-2-diabetes-and-mild-hyperglycemia-22995 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-vildagliptin-on-the-maximum-insulin-secretion-in-patients-with-type-2-diabetes-22996 https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-acarbose-in-drug-naive-patients-with-type-2-diabetes-22997 https://curecurrent.com/trials/influence-of-different-approaches-to-dietary-advising-on-the-effects-of-acarbose-treatment-in-obese-diabetic-patients-un-22998 https://curecurrent.com/trials/glycemic-holter-study-continuous-glucose-monitoring-22999 https://curecurrent.com/trials/nt-probnp-guided-primary-prevention-of-cv-events-in-diabetic-patients-23000 https://curecurrent.com/trials/a-clinical-study-to-assess-the-effect-of-vildagliptin-on-postprandial-lipid-parameters-in-patients-with-type-2-diabetes-23001 https://curecurrent.com/trials/pharmacokinetic-study-of-laf237-and-its-metabolites-in-mild-renal-impaired-patients-23002 https://curecurrent.com/trials/a-clinical-study-to-assess-the-efficacy-and-safety-of-vildagliptin-in-patients-with-type-2-diabetes-23003 https://curecurrent.com/trials/effects-of-short-term-intensive-insulin-therapy-in-newly-diagnosed-type-2-diabetes-patients-23004 https://curecurrent.com/trials/evaluation-of-the-performance-and-use-of-non-invasive-glucose-monitoring-device-23005 https://curecurrent.com/trials/extension-study-of-the-long-term-safety-and-tolerability-of-octreotide-acetate-in-patients-with-moderately-severe-or-sev-23006 https://curecurrent.com/trials/attachment-style-of-type-2-diabetics-and-cognitive-social-and-emotional-variables-as-explanatory-factors-of-adherence-to-23007 https://curecurrent.com/trials/single-dose-study-with-a-new-insulin-glargine-formulation-and-lantus-in-japanese-patients-with-type-1-diabetes-mellitus-23008 https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-inhaled-technosphere-insulin-in-patients-with-type-2-diabetes-23009 https://curecurrent.com/trials/igf-i-induced-muscle-glucose-uptake-and-interstitial-igf-i-concentrations-23010 https://curecurrent.com/trials/pharmaceutical-care-of-patients-with-impaired-mobility-in-a-model-region-of-decreasing-supply-of-medical-services-23011 https://curecurrent.com/trials/18-week-randomized-double-blind-placebo-controlled-forced-titration-study-of-patients-with-type-2-diabetes-23012 https://curecurrent.com/trials/use-of-beta-blockers-and-risk-of-new-onset-diabetes-23013 https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effects-of-nateglinide-vs-glibenclamide-on-renal-hemodynamics-and-albumin-excretion-23014 https://curecurrent.com/trials/islet-allotransplantation-with-steroid-free-immunosuppression-23015 https://curecurrent.com/trials/metabolic-effects-of-a-pre-meal-protein-drink-with-or-without-added-amino-acids-at-a-subsequent-composite-meal-23016 https://curecurrent.com/trials/vitamin-d-receptor-polymorphisms-and-efficacy-of-vitamin-d-fortified-yogurt-drink-in-patients-with-type-2-diabetes-23017 https://curecurrent.com/trials/small-dense-low-density-lipoprotein-in-patients-with-prediabetes-and-type-2-diabetes-23018 https://curecurrent.com/trials/point-of-care-hba1c-as-a-screening-test-for-type-2-diabetes-in-first-nations-23019 https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-blood-pressure-and-hba1c-levels-in-patients-with-t2d-23020 https://curecurrent.com/trials/randomized-double-blind-study-to-assess-the-efficacy-and-safety-of-lipoic-acid-versus-bk-c-0701-in-subjects-with-diabeti-23021 https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-in-the-context-of-exercise-in-adults-with-type-1-diabetes-23022 https://curecurrent.com/trials/dose-effect-relationship-of-low-dose-il-2-in-type-1-diabetes-23023 https://curecurrent.com/trials/assessment-of-the-effect-of-tegaserod-2-mg-tid-and-6-mg-tid-on-dyspeptic-symptoms-in-diabetic-patients-with-symptoms-of-23024 https://curecurrent.com/trials/accuracy-reliability-and-safety-of-glucomen-day-a-new-generation-microdialysis-continuous-glucose-monitor-23025 https://curecurrent.com/trials/investigation-of-the-impact-of-different-application-volumes-of-insulin-aspart-in-subjects-with-type-1-diabetes-23026 https://curecurrent.com/trials/the-effect-of-green-tea-or-cocoa-extracts-in-endothelial-dysfunction-in-patients-with-diabetes-mellitus-23027 https://curecurrent.com/trials/the-adherence-index-the-indicator-of-effective-coping-with-the-requirements-of-the-disease-of-children-and-adolescents-w-23028 https://curecurrent.com/trials/training-detraining-retraining-and-glycemic-control-in-patients-with-type-2-diabetes-23029 https://curecurrent.com/trials/plant-stanols-and-type-1-diabetes-23030 https://curecurrent.com/trials/dietary-modulation-of-gene-expression-and-metabolic-pathways-in-glucose-metabolism-23031 https://curecurrent.com/trials/safety-and-efficacy-of-single-administration-of-oshadi-oral-insulin-in-type-i-diabetes-patients-23032 https://curecurrent.com/trials/the-effect-of-nordic-recommended-diet-on-the-features-of-metabolic-syndrome-multicentre-study-23033 https://curecurrent.com/trials/evaluating-the-effects-of-electroacupuncture-and-rosiglitazone-combined-therapy-23034 https://curecurrent.com/trials/effect-of-a-vitamin-d-analogue-vs-placebo-on-p-nt-probnp-in-patients-with-type-1-dm-and-diabetic-nephropathy-23035 https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-for-the-treatment-of-type-2-diabetes-mellitus-23036 https://curecurrent.com/trials/a-study-of-insulin-lispro-mix-in-type-2-diabetic-asian-patients-23037 https://curecurrent.com/trials/effect-of-linagliptin-in-comparison-with-glimepiride-as-add-on-to-metformin-on-postprandial-beta-cell-function-postprand-23038 https://curecurrent.com/trials/role-of-rosiglitazone-on-pre-diabetes-mellitus-and-coronary-artery-disease-23039 https://curecurrent.com/trials/assessment-of-the-clinical-efficacy-and-acceptability-of-think-positive-t-in-diabetes-management-23040 https://curecurrent.com/trials/extension-study-of-long-term-safety-and-tolerability-of-octreotide-acetate-in-patients-with-moderately-severe-or-severe-23041 https://curecurrent.com/trials/effect-of-meal-frequency-on-insulin-resistance-in-subjects-with-type-2-diabetes-23042 https://curecurrent.com/trials/a-first-time-in-human-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ascending-doses-o-23043 https://curecurrent.com/trials/phielix-et-al-hepatic-fat-content-and-adipokines-23044 https://curecurrent.com/trials/adiponectin-and-asymmetric-dimethylarginine-adma-level-in-type-2-diabetes-patients-after-12-weeks-of-treatment-with-glim-23045 https://curecurrent.com/trials/effect-of-incretin-related-drugs-on-dietary-intake-in-japanese-patients-with-type-2-diabetes-mellitus-23046 https://curecurrent.com/trials/glufast-on-insulin-glargine-trial-in-type-2-dm-23047 https://curecurrent.com/trials/mycophenolate-mofetil-carnitine-and-pde5-inhibitor-three-potential-treatments-for-resistant-proteinuria-slowing-diabetic-23048 https://curecurrent.com/trials/effect-of-adding-vildagliptin-on-beta-cell-function-and-cardiovascular-risk-markers-in-patients-with-moderate-metabolic-23049 https://curecurrent.com/trials/insulin-glargine-for-diabetes-metabolism-dm-type-ii-patients-under-enteral-nutrition-23050 https://curecurrent.com/trials/diabetes-mellitus-care-decision-making-model-through-data-mining-23051 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-fixed-dose-rosiglitazone-glimepiride-to-treat-chinese-type-2-diabetes-patients-23052 https://curecurrent.com/trials/clinical-usefulness-of-a-magnifier-for-insulin-pen-23053 https://curecurrent.com/trials/stressors-coping-methods-and-social-support-in-diabetic-patients-23054 https://curecurrent.com/trials/the-effect-of-anakinra-on-insulin-secretion-23055 https://curecurrent.com/trials/potential-beneficial-effects-of-resveratrol-23056 https://curecurrent.com/trials/cdrm-study-computer-assisted-diabetes-risk-management-for-secondary-and-tertiary-prevention-of-t2dm-complications-23057 https://curecurrent.com/trials/self-titration-with-apidra-to-reach-target-study-start-23058 https://curecurrent.com/trials/evaluation-of-negative-pressure-wound-therapy-in-the-treatment-of-dfus-incl-post-amputation-wounds-23059 https://curecurrent.com/trials/exploring-buckwheat-s-glucose-lowering-potential-23060 https://curecurrent.com/trials/52-week-add-on-to-metformin-comparison-of-saxagliptin-and-sulphonylurea-with-a-52-week-extension-period-23061 https://curecurrent.com/trials/bone-marrow-autotransplantation-in-type-1-diabetes-23062 https://curecurrent.com/trials/prevalence-of-peripheral-arterial-disease-in-subject-with-a-moderate-risk-of-cardiovascular-cv-disease-cvd-in-primary-pr-23063 https://curecurrent.com/trials/intensive-insulin-therapy-in-non-diabetic-patients-with-acute-myocardial-infarction-and-hyperglycaemia-23064 https://curecurrent.com/trials/long-term-of-10-years-results-of-a-prospective-longitudinal-study-23065 https://curecurrent.com/trials/a-double-blind-randomized-active-comparator-metformin-controlled-clinical-trial-to-study-the-efficacy-and-safety-of-the-23066 https://curecurrent.com/trials/a-dose-finding-study-of-topically-applied-i-020201-as-an-adjunct-to-good-standard-of-care-in-patients-with-chronic-diabe-23067 https://curecurrent.com/trials/metabolic-effects-of-honey-in-type-1-diabetes-mellitus-23068 https://curecurrent.com/trials/effect-of-dpp-iv-inhibitor-on-glycemic-control-and-autonomic-neuropathy-in-adult-patients-with-diabetes-mellitus-23069 https://curecurrent.com/trials/prevalence-of-subclinical-atherosclerosis-and-its-associated-factors-in-hyperlipidemic-korean-adults-with-diabetes-23070 https://curecurrent.com/trials/effect-of-palm-sugar-on-blood-glucose-concentrations-23071 https://curecurrent.com/trials/2-5-and-10-phenylephrine-for-mydriasis-in-diabetic-patients-with-darkly-pigmented-irides-23072 https://curecurrent.com/trials/sulfonylurea-effects-on-glucagon-regulation-during-hypoglycemia-in-type-1-dm-23073 https://curecurrent.com/trials/comparing-the-efficacy-of-the-convatec-engenex-negative-pressure-wound-therapy-device-to-moist-wound-therapy-23074 https://curecurrent.com/trials/evaluate-efficacy-and-safety-of-saxagliptin-in-combination-with-metformin-in-adult-patients-with-type-2-diabetes-23075 https://curecurrent.com/trials/basal-insulin-for-type-2-diabetes-patients-treated-in-outpatient-clalit-clinics-23076 https://curecurrent.com/trials/effects-of-n-acetylcysteine-on-diabetic-foot-oxygenation-23077 https://curecurrent.com/trials/weight-loss-maintenance-wlm-23078 https://curecurrent.com/trials/comparison-of-amlodipine-and-aliskiren-in-diabetic-hypertensive-patient-with-blood-pressure-not-controlled-by-losartan-23079 https://curecurrent.com/trials/human-insulin-analogs-evaluation-of-inflammatory-mrna-expression-of-macrophages-and-endothelial-function-of-short-acting-23080 https://curecurrent.com/trials/human-islet-transplantation-in-brittle-type-1-diabetes-mellitus-the-gragil-2-study-23081 https://curecurrent.com/trials/effects-of-exercise-on-srage-levels-and-cardiometabolic-risk-factors-23082 https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-dapagliflozin-as-monotherapy-in-subjects-with-type-2-diabetes-who-have-inadequate-g-23083 https://curecurrent.com/trials/effect-of-mental-stress-on-glucose-control-in-patients-with-diabetes-mellitus-23084 https://curecurrent.com/trials/efficacy-of-pioglitazone-on-macrovascular-outcome-in-patients-with-type-2-diabetes-23085 https://curecurrent.com/trials/safety-comparison-of-pioglitazone-and-glyburide-in-type-2-diabetes-subjects-with-mild-to-moderate-congestive-heart-failu-23086 https://curecurrent.com/trials/efficacy-of-pioglitazone-compared-to-glyburide-in-treating-subjects-with-type-2-diabetes-mellitus-and-mild-cardiac-disea-23087 https://curecurrent.com/trials/safety-study-of-pioglitazone-compared-to-glyburide-on-liver-function-23088 https://curecurrent.com/trials/efficacy-of-pioglitazone-on-microcirculation-in-type-2-diabetes-patients-treated-with-insulin-23089 https://curecurrent.com/trials/observational-study-to-assess-glycosylated-hemoglobin-changes-after-6-months-of-treatment-with-pioglitazone-23090 https://curecurrent.com/trials/safety-study-of-tak-128-in-subjects-with-diabetic-peripheral-neuropathy-23091 https://curecurrent.com/trials/safety-and-efficacy-of-tak-559-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-23092 https://curecurrent.com/trials/lixisenatide-for-restoration-of-insulin-release-in-subjects-with-diabetes-mellitus-type-2-23093 https://curecurrent.com/trials/retrospective-study-hip-fractures-in-diabetic-patients-23094 https://curecurrent.com/trials/mr-evaluation-of-renal-function-after-pancreas-transplantation-23095 https://curecurrent.com/trials/telephone-intervention-in-patients-with-acute-coronary-syndrome-acs-and-diabetes-23096 https://curecurrent.com/trials/stem-cell-educator-therapy-in-type-2-diabetes-23097 https://curecurrent.com/trials/pump-study-mdi-lantus-lispro-vs-continuous-insulin-lispro-23098 https://curecurrent.com/trials/effect-of-vasopressin-on-tissue-oxygen-saturation-in-cardiac-surgery-patients-during-cardiopulmonary-bypass-23099 https://curecurrent.com/trials/polyphenols-and-insulin-resistance-23100 https://curecurrent.com/trials/japanese-single-and-multiple-ascending-dose-safety-tolerability-pharmacokinetic-pk-pharmacodynamic-pd-study-of-azd7687-23101 https://curecurrent.com/trials/safety-tolerability-and-pharmacodynamics-of-cyt013-il1bqb-in-patients-with-type-2-diabetes-23102 https://curecurrent.com/trials/are-the-continuous-glucose-monitoring-systems-able-to-improve-long-term-glycaemic-control-in-type-1-diabetic-patients-23103 https://curecurrent.com/trials/comparison-of-door-to-door-versus-community-gathering-to-provide-hiv-counseling-and-testing-services-in-rural-lesotho-23104 https://curecurrent.com/trials/detecting-diabetes-sooner-with-a-risk-survey-for-the-family-doctor-comparing-internet-and-traditional-methods-of-communi-23105 https://curecurrent.com/trials/multicenter-assessment-of-the-pda-fit-system-in-type-1-diabetic-patients-23106 https://curecurrent.com/trials/immune-and-metabolic-effects-of-vitamin-d-supplementation-in-healthy-humans-23107 https://curecurrent.com/trials/effect-of-treatment-with-metformin-in-type-2-diabetes-patients-on-alternative-genes-splicing-23108 https://curecurrent.com/trials/improved-outcomes-associated-with-inositol-dietary-supplementation-in-women-with-gestational-diabetes-mellitus-23109 https://curecurrent.com/trials/roux-en-y-versus-billroth-ii-reconstruction-after-subtotal-gastrectomy-in-gastric-cancer-comorbid-with-type-ii-diabetes-23110 https://curecurrent.com/trials/the-verona-newly-diagnosed-type-2-diabetes-study-23111 https://curecurrent.com/trials/clinical-decision-support-for-women-with-a-history-of-gestational-diabetes-23112 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-combination-with-thiazolidine-in-participants-with-type-2-diabetes-in-japan-23113 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-in-combination-with-glucosidase-inhibitor-in-participants-with-type-2-diabetes-in-23114 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-combination-with-metformin-in-participants-with-type-2-diabetes-in-japan-23115 https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-in-participants-with-type-2-diabetes-in-japan-23116 https://curecurrent.com/trials/study-for-the-artificial-pancreas-project-determination-of-a-tuning-strategy-of-metabolic-profiles-23117 https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-thiazolidine-in-participants-with-type-2-diabetes-in-japan-23118 https://curecurrent.com/trials/affect-of-rt-cgms-as-part-of-clinical-care-in-type-1-diabetes-mellitus-patients-23119 https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-glucosidase-inhibitor-in-participants-with-type-2-diabetes-23120 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-in-participants-with-type-2-diabetes-in-japan-23121 https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-in-combination-with-sulfonylurea-in-participants-with-type-2-diabetes-in-japan-23122 https://curecurrent.com/trials/safety-tolerability-and-activity-study-of-multiple-doses-of-isis-sglt2rx-in-healthy-volunteers-23123 https://curecurrent.com/trials/safety-and-efficacy-study-of-alogliptin-on-glycemic-control-in-subjects-with-type-2-diabetes-23124 https://curecurrent.com/trials/evaluation-of-the-tantalus-system-in-type-2-diabetic-subjects-23125 https://curecurrent.com/trials/efficacy-and-safety-of-tak-559-combined-with-glyburide-in-treating-subjects-with-type-2-diabetes-mellitus-23126 https://curecurrent.com/trials/a-study-of-three-pf-05190457-formulations-in-healthy-volunteers-23127 https://curecurrent.com/trials/effect-of-dietary-protein-restriction-on-prognosis-in-patients-with-diabetic-nephropathy-23128 https://curecurrent.com/trials/metformin-effects-on-oxidative-stress-parameters-in-newly-diagnosed-type-2-diabetes-patients-23129 https://curecurrent.com/trials/diabetes-in-europe-prevention-using-lifestyle-physical-activity-and-nutritional-intervention-in-catalonia-23130 https://curecurrent.com/trials/long-term-diabetes-improvement-after-cancer-gastrectomy-and-colectomy-23131 https://curecurrent.com/trials/balance-system-study-in-type-2-diabetic-patients-23132 https://curecurrent.com/trials/the-influence-of-adalimumab-on-cardiovascular-and-metabolic-risk-in-psoriasis-23133 https://curecurrent.com/trials/efficacy-and-tolerability-of-saxagliptin-add-on-compared-to-uptitration-of-metformin-in-patients-with-type-2-diabetes-23134 https://curecurrent.com/trials/efficacy-of-myo-inositol-in-preventing-gestational-diabetes-in-high-risk-pregnant-women-23135 https://curecurrent.com/trials/risk-and-prevention-study-evaluation-of-the-efficacy-of-n-3-pufa-in-subjects-at-high-cardiovascular-risk-23136 https://curecurrent.com/trials/the-effect-of-macronutrients-in-the-diet-on-digestive-and-cardiovascular-health-23137 https://curecurrent.com/trials/comparison-of-efficacy-of-vitamin-d-and-vitamin-d-calcium-fortified-yogurt-drink-in-diabetic-patients-23138 https://curecurrent.com/trials/the-titan-versus-everolimus-intracoronary-stent-xience-v-in-diabetic-patients-23139 https://curecurrent.com/trials/study-of-metabolic-and-haemodynamic-effects-of-metformin-and-glimepiride-in-patients-with-type-2-diabetes-mellitus-23140 https://curecurrent.com/trials/the-effect-of-fragmin-in-the-treatment-of-neuroischaemic-foot-ulcers-in-diabetic-patients-a6301086-23141 https://curecurrent.com/trials/a-study-to-evaluate-p-glucose-safety-and-tolerability-after-oral-single-dosing-of-azd6370-in-type-2-diabetic-patients-23142 https://curecurrent.com/trials/insulin-glargine-first-line-vs-metformin-in-type-2-diabetic-subjects-23143 https://curecurrent.com/trials/risk-evaluation-of-cancers-in-chinese-diabetic-individuals-a-longitudinal-study-23144 https://curecurrent.com/trials/the-effect-of-a-nutritional-supplement-in-individuals-with-type-2-diabetes-mellitus-a-pilot-study-23145 https://curecurrent.com/trials/predictive-parameters-for-efficacy-of-sitagliptin-and-metformin-combination-23146 https://curecurrent.com/trials/botulinum-toxin-a-for-treatment-of-catocholamine-induced-finger-necrosis-23147 https://curecurrent.com/trials/performance-evaluation-of-blood-glucose-monitoring-systems-23148 https://curecurrent.com/trials/exercise-intensity-glycemic-control-and-abdominal-fat-in-people-with-type-2-diabetes-a-pilot-study-23149 https://curecurrent.com/trials/a-safety-pk-pd-study-of-slv337-in-patients-with-type-2-diabetes-23150 https://curecurrent.com/trials/beta-cell-function-and-sitagliptin-trial-best-23151 https://curecurrent.com/trials/insulin-detemir-action-in-cerebro-23152 https://curecurrent.com/trials/performance-study-of-the-solo-2-0-insulin-pump-23153 https://curecurrent.com/trials/establishing-cardiovascular-biomarkers-to-define-preferred-lantus-use-23154 https://curecurrent.com/trials/comparing-the-expected-benefit-of-extra-corporeal-shockwave-therapy-eswt-treatment-to-standard-care-in-treating-diabetic-23155 https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-on-arterial-stiffness-in-diabetic-patients-23156 https://curecurrent.com/trials/treatment-effects-of-atorvastatin-on-hemostasis-and-skin-microcirculation-in-patients-with-type-1-diabetes-23157 https://curecurrent.com/trials/oral-bbr-012-in-the-treatment-of-diabetic-foot-ulcers-proof-of-concept-study-23158 https://curecurrent.com/trials/effect-of-organic-naked-oat-with-whole-germ-on-type-2-diabetes-mellitus-23159 https://curecurrent.com/trials/vitamin-d-inadequacy-on-postprandial-glucose-in-type-2-diabetes-mellitus-23160 https://curecurrent.com/trials/bevacizumab-versus-ranibizumab-for-the-treatment-of-diabetic-macular-edema-23161 https://curecurrent.com/trials/pre-mix-insulin-lispro-treatment-for-type-2-diabetes-patients-who-consume-a-light-breakfast-23162 https://curecurrent.com/trials/exercise-and-pregnancy-randomized-clinical-trial-23163 https://curecurrent.com/trials/macrophage-infiltration-in-human-adipose-tissue-23164 https://curecurrent.com/trials/a-study-to-evaluate-the-postprandial-metabolic-response-after-use-of-glucerna-sr-in-obese-type-2-diabetes-23165 https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-rosuvastatin-versus-simvastatin-in-type-2-diabetic-patients-with-dyslipidemia-23166 https://curecurrent.com/trials/chinese-medicine-treatment-of-obesity-with-type-2-diabetes-dyslipidemia-23167 https://curecurrent.com/trials/comparison-between-low-carbohydrate-diet-and-traditionally-recommended-diabetic-diet-in-the-treatment-of-diabetes-mellit-23168 https://curecurrent.com/trials/genetic-association-of-diabetic-retinopathy-1-23169 https://curecurrent.com/trials/a-study-of-ly2599506-oral-agent-medication-glucokinase-activator-1-in-type-2-diabetes-mellitus-23170 https://curecurrent.com/trials/influence-of-acupuncture-to-ocular-microcirculation-in-patients-with-diabetes-mellitus-23171 https://curecurrent.com/trials/effectiveness-of-nursing-care-plans-based-in-nursing-diagnoses-in-metabolic-control-of-type-2-diabetes-mellitus-23172 https://curecurrent.com/trials/diabetes-resolution-and-hormone-changes-after-bpdll-and-lsg-23173 https://curecurrent.com/trials/evaluation-of-posterior-capsule-opacification-in-eyes-with-diabetes-mellitus-23174 https://curecurrent.com/trials/prevention-of-diabetes-mellitus-type-2-in-women-post-gestational-diabetes-mellitus-diagnosis-23175 https://curecurrent.com/trials/medium-term-health-coaching-and-life-long-monitoring-in-cardiovascular-disease-in-norrbotten-23176 https://curecurrent.com/trials/comparison-of-morning-and-evening-dosing-of-valsartan-and-lisinopril-in-patients-with-diabetes-23177 https://curecurrent.com/trials/low-dose-carotene-supplementation-diminishes-oxidative-stress-in-type-2-diabetics-and-healthy-individuals-23178 https://curecurrent.com/trials/managing-diabetes-during-pregnancy-in-the-wireless-age-23179 https://curecurrent.com/trials/structured-diabetes-self-management-education-in-primary-care-and-metabolic-control-23180 https://curecurrent.com/trials/effectiveness-of-the-self-monitoring-of-capillary-blood-glucose-at-home-23181 https://curecurrent.com/trials/oxidative-stress-markers-evaluation-before-and-after-periodontal-treatment-of-diabetics-type-2-patients-23182 https://curecurrent.com/trials/laparoscopic-adjustable-gastric-banding-with-truncal-vagotomy-23183 https://curecurrent.com/trials/study-to-improve-quality-of-care-and-patient-health-in-the-field-of-cardiovascular-risk-factors-in-general-practice-23184 https://curecurrent.com/trials/is-there-a-metabolic-effect-of-cinnamon-on-hba1c-blood-pressure-and-serum-lipids-in-type-2-diabetes-mellitus-23185 https://curecurrent.com/trials/effectiveness-and-safety-of-two-approaches-to-the-management-of-type-2-diabetes-mellitus-in-australian-primary-care-23186 https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-fasting-glucose-and-interleukin-10-il-10-in-arab-women-with-impaired-fasting-gluc-23187 https://curecurrent.com/trials/copeptin-for-risk-stratification-in-acute-stroke-patients-the-corisk-study-23188 https://curecurrent.com/trials/the-effect-of-glycemic-control-on-malondialdehyde-glutathione-peroxidase-glutathione-and-paraoxonase-23189 https://curecurrent.com/trials/evaluation-of-cissus-verticillata-l-infusion-in-controlling-type-2-diabetes-23190 https://curecurrent.com/trials/the-effect-of-roux-en-y-gastric-bypass-on-mitochondrial-function-in-type-2-diabetes-23191 https://curecurrent.com/trials/diabetogenicity-of-cyclosporine-and-tacrolimus-23192 https://curecurrent.com/trials/valsartan-hydrochlorothiazide-combination-vs-amlodipine-in-patients-with-hypertension-diabetes-and-albuminuria-23193 https://curecurrent.com/trials/antialbuminuric-effects-of-valsartan-and-lisinopril-23194 https://curecurrent.com/trials/effect-of-valsartan-on-proteinuria-in-patients-with-hypertension-and-diabetes-mellitus-23195 https://curecurrent.com/trials/effects-of-exercise-intervention-and-rehabilitation-exercise-intervention-in-patients-with-type-2-diabetes-23196 https://curecurrent.com/trials/managing-insulin-pumps-for-exercise-study-1-23197 https://curecurrent.com/trials/comparing-long-acting-insulins-during-exercise-in-type-1-diabetes-23198 https://curecurrent.com/trials/hyperbaric-oxygen-therapy-as-adjunctive-treatment-of-chronic-diabetic-foot-ulcers-23199 https://curecurrent.com/trials/vldl-triglyceride-kinetics-in-type-2-diabetes-23200 https://curecurrent.com/trials/immune-profile-and-complication-risk-in-type-2-diabetes-23201 https://curecurrent.com/trials/n-3-fatty-acid-infusion-and-type-2-diabetes-23202 https://curecurrent.com/trials/single-anastomosis-duodeno-ileal-bypass-with-sleeve-gastrectomy-sadi-s-for-the-treatment-of-morbid-obesity-and-its-metab-23203 https://curecurrent.com/trials/comparing-the-metabolic-control-of-once-to-twice-daily-insulin-detemir-injections-23204 https://curecurrent.com/trials/effects-of-rosiglitazone-on-renal-hemodynamics-and-proteinuria-of-type-2-diabetic-patients-with-renal-insufficiency-due-23205 https://curecurrent.com/trials/euglycemic-clamp-dose-response-study-comparing-a-new-insulin-glargine-formulation-with-lantus-23206 https://curecurrent.com/trials/influence-of-pioglitazone-for-renal-transplant-function-in-diabetics-23207 https://curecurrent.com/trials/peripheral-endothelial-function-and-coronary-status-in-asymptomatic-diabetic-patients-23208 https://curecurrent.com/trials/effect-of-mulberry-leaf-extract-on-blood-glucose-23209 https://curecurrent.com/trials/stress-relief-management-for-treatment-of-late-complications-in-type-2-diabetes-23210 https://curecurrent.com/trials/aspirin-statins-or-both-for-the-reduction-of-thrombin-generation-in-diabetic-people-23211 https://curecurrent.com/trials/self-monitoring-of-blood-glucose-in-insulin-treated-patients-with-type-2-diabetes-23212 https://curecurrent.com/trials/glycemic-and-blood-pressure-control-in-type-2-diabetes-in-a-primary-care-unit-a-staged-management-strategy-23213 https://curecurrent.com/trials/cabergoline-effect-on-blood-sugar-in-type-2-diabetics-23214 https://curecurrent.com/trials/low-grade-inflammation-in-type-1-diabetes-children-23215 https://curecurrent.com/trials/educative-intervention-to-improve-type-2-diabetes-mellitus-control-in-corrientes-23216 https://curecurrent.com/trials/effects-of-food-advanced-glycation-endproducts-on-vascular-function-in-diabetes-23217 https://curecurrent.com/trials/integrating-insulin-delivery-and-glucose-sensing-in-subcutaneous-tissue-for-the-treatment-of-type-1-diabetic-patients-23218 https://curecurrent.com/trials/pathology-of-skin-nerve-and-vasculature-in-the-amputated-limb-of-diabetes-23219 https://curecurrent.com/trials/drug-drug-interaction-study-of-dapagliflozin-with-voglibose-in-japanese-type-2-diabetes-mellitus-patients-23220 https://curecurrent.com/trials/organization-program-of-diabetes-insulin-management-23221 https://curecurrent.com/trials/resistant-hypertension-in-patients-with-type-ii-diabetes-mellitus-23222 https://curecurrent.com/trials/evaluation-of-the-effect-of-vivostat-platelet-rich-fibrin-prf-in-the-treatment-of-diabetic-foot-ulcers-23223 https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-impact-of-diamyd-in-patients-newly-diagnosed-with-type-1-diabetes-eu-23224 https://curecurrent.com/trials/the-role-of-endogenous-glucagon-like-peptide-1-glp-1-in-type-2-diabetes-mellitus-t2dm-23225 https://curecurrent.com/trials/caloric-restriction-and-insulin-secretion-23226 https://curecurrent.com/trials/assessment-of-an-alternative-model-of-follow-up-of-children-and-adolescents-with-type-1-diabetes-23227 https://curecurrent.com/trials/effect-of-sitagliptin-on-incretin-effect-in-patients-with-type-2-diabetes-mellitus-23228 https://curecurrent.com/trials/vinegar-co-ingestion-in-type-2-diabetes-23229 https://curecurrent.com/trials/evaluation-of-interests-of-fit-therapy-on-diabetics-children-insulin-dependent-23230 https://curecurrent.com/trials/nerve-conduction-velocity-in-diabetic-children-23231 https://curecurrent.com/trials/effect-of-self-monitoring-of-blood-glucose-in-patients-with-type-2-diabetes-mellitus-not-using-insulin-23232